Other disorders of the musculoskeletal system and connective tissue

M13_MUSCULOSKELEOTH

musculoskeletal system disease: A disease involving the musculoskeletal system. [database_cross_reference: MONDO:DesignPattern]

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M95-M99 Cause of death: ICD-10 — M95-M99 2 out of 7 registries used, show all original rules.	5533
4. Check minimum number of events None	5533
5. Include endpoints M13_DEFORMACQ M13_POSTOPMUSCULOSKE M13_BIOMECHLESIO	7241
6. Filter based on genotype QC (FinnGen only)	6489

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	M13_MUSCULOSKELEOTH
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_DEFORMACQ\|M13_POSTOPMUSCULOSKE\|M13_BIOMECHLESIO
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M9[5-9]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M9[5-9]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other disorders of the musculoskeletal system and connective tissue based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	42034	22263	19467
Only index persons	37295	20148	17147
Unadjusted period prevalence (%)
Whole population	0.59	0.64	0.54
Only index persons	0.70	0.74	0.65
Median age at first event (years)
Whole population	50.65	53.46	47.40
Only index persons	49.27	52.21	45.81

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6489	3704	2785
Unadjusted period prevalence (%)	1.30	1.32	1.28
Median age at first event (years)	53.92	52.97	55.19

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6718: Matched controls
67180

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

6.4

316.2

546

909

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

37.9

316.0

195

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

18.3

314.4

253

143

N02BF01

ATC

gabapentin; oral

3.5

310.5

1283

4275

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

6.3

309.3

546

929

DLD20

NOMESCO Finland

Rhinoplasty

175.8

307.7

270

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

12.3

307.7

584

518

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

1227.3

307.7

950

M99.6

ICD-10 Finland

Osseous and subluxation stenosis of intervertebral foramina

140.5

307.7

334

M54.4

ICD-10 Finland

Lumbago with sciatica

3.0

307.7

1926

7928

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

24.3

307.7

260

111

N02AX02

ATC

tramadol; systemic, rectal

3.2

307.7

4126

22226

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

11.4

307.7

376

348

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

194.8

307.7

488

N03AX12

ATC

[U] gabapentin; oral

4.0

307.7

2115

6943

7228C

ICD-9 Finland

Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]

+∞

307.7

431

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

6.0

307.7

631

1144

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.7

307.7

1818

6126

DLD10

NOMESCO Finland

Reconstruction of cartilage and bone of nose

166.6

307.7

241

M48.0

ICD-10 Finland

Spinal stenosis

5.5

307.7

2105

5183

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

4.1

307.7

1912

5972

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

11.0

307.7

437

422

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

7.6

307.7

581

823

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.3

307.7

1408

3902

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

4.5

307.7

950

2368

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.0

307.7

1421

4219

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

6.4

307.7

973

1729

73808

ICD-8 Finland

Other deformities, Aliae definitae

+∞

307.7

358

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

17.2

307.7

272

164

M95.0

ICD-10 Finland

Acquired deformity of nose

1433.5

307.7

874

M99.5

ICD-10 Finland

Intervertebral disc stenosis of neural canal

111.0

307.7

215

N03AX16

ATC

[U] pregabalin

3.4

307.7

2613

10637

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

3111.3

307.7

853

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

3826.3

307.7

709

M43.1

ICD-10 Finland

Spondylolisthesis

6.4

307.7

740

1274

M99.9

ICD-10 Finland

Biomechanical lesion, unspecified

110.3

294.7

151

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

7.7

293.6

426

588

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.3

286.9

508

866

9211

FHL

Exploration or removal of diskusprolapse

7.7

286.7

413

565

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.7

286.7

1036

3153

M99.0

ICD-10 Finland

Segmental and somatic dysfunction

100.6

266.6

138

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.4

259.0

3677

22599

N06AX21

ATC

duloxetine; oral

3.1

258.1

1294

4805

7396A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Lower extremities

+∞

247.4

236

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.8

246.5

1617

6932

M54.5

ICD-10 Finland

Low back pain

2.3

243.6

3104

18061

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

5.0

237.1

535

1136

M99.8

ICD-10 Finland

Other biomechanical lesions

263.6

224.6

229

N02AJ06

ATC

codeine and paracetamol; systemic

2.2

218.8

3496

22027

N06AA09

ATC

amitriptyline; systemic

3.1

216.3

1039

3738

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

15.7

215.9

187

122

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

4.5

213.5

547

1287

ZZH31

NOMESCO Finland

Bone allograft, small pieces

12.7

212.7

209

170

M79.6

ICD-10 Finland

Pain in limb

2.2

210.5

3569

22900

DLD00

NOMESCO Finland

Reconstruction of cartilage of nose

42.4

208.7

125

J34.2

ICD-10 Finland

Deviated nasal septum

4.0

208.2

640

1726

L86

ICPC

Back syndrome with radiating pain

3.6

203.5

750

2289

NFJ64

NOMESCO Finland

Other internal fixation of fracture of other parts of femur

23.1

202.8

147

L03

ICPC

Low back symptom/complaint

2.2

200.6

2481

13977

9183

FHL

Posterolateral spondylodesis

50.4

197.8

114

7384A

ICD-9 Finland

Other acquired deformity, Acquired spondylolisthesis

+∞

194.7

186

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.2

189.6

528

1322

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.7

188.3

1228

5180

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.0

188.3

960

3556

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

187.1

2155

11730

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.1

186.8

858

2994

B01AB05

ATC

enoxaparin; parenteral

2.1

186.4

2628

15487

N02AA05

ATC

oxycodone; systemic

2.3

180.7

1690

8412

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

19.0

177.9

140

X59

ICD-10 Finland

Exposure to unspecified factor

2.3

176.3

1668

8332

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

5.0

174.8

390

817

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

11.7

174.4

180

158

NF3AA

NOMESCO Finland

Femur X-ray examination

5.6

173.6

341

638

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

3.2

169.9

740

2496

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

3.0

169.5

814

2907

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.7

169.2

1052

4315

M43.0

ICD-10 Finland

Spondylolysis

6.5

167.7

279

444

WX402

NOMESCO Finland

General anaesthesia

2.2

163.4

1870

10060

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

5.8

162.4

303

540

N02BF02

ATC

pregabalin; oral

3.1

161.8

736

2544

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

4.3

161.4

434

1056

NF1AA

NOMESCO Finland

Hip X-ray examination

2.8

160.5

944

3758

WX704

NOMESCO Finland

Intubation

2.9

160.3

841

3150

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

157.5

1199

5410

M01AH05

ATC

etoricoxib; oral

2.0

156.8

4562

34135

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

156.4

724

2527

73809

ICD-8 Finland

Other deformities, Unspecified

+∞

155.8

149

M47.9

ICD-10 Finland

Spondylosis, unspecified

4.3

154.4

424

1048

L28

ICPC

Limited function/disability (L)

2.2

154.2

1709

9046

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

151.3

2543

15691

S72.3

ICD-10 Finland

Fracture of shaft of femur

9.0

150.9

187

212

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

149.8

1848

10181

M54.1

ICD-10 Finland

Radiculopathy

3.8

148.6

478

1324

WX320

NOMESCO Finland

Spinalanesthesy

2.1

147.3

2030

11644

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.4

144.9

381

910

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

143.1

995

4288

N02AC04

ATC

dextropropoxyphene; oral

4.0

141.4

419

1094

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

140.5

2695

17286

WX725

NOMESCO Finland

Noninvasive ventilation

3.2

139.3

600

2003

R52.2

ICD-10 Finland

Other chronic pain

3.8

138.8

443

1219

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

138.3

2781

18091

M96.8

ICD-10 Finland

Other postprocedural musculoskeletal disorders

351.9

138.3

139

ZZG00

NOMESCO Finland

Graft of cartilage

38.7

136.9

M03BX02

ATC

tizanidine; oral

1.9

135.9

4395

33251

L17

ICPC

Foot/toe symptom/complaint

1.9

135.2

2426

15170

S18

ICPC

Laceration/cut

1.9

135.0

3574

25332

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.0

134.9

664

2392

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

132.2

1174

5634

DJD20

NOMESCO Finland

Plastic repair of septum of nose

3.9

130.0

403

1086

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.3

128.8

1096

5160

M54.3

ICD-10 Finland

Sciatica

3.0

127.0

620

2221

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

4.2

126.8

354

884

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.5

125.9

246

457

M01AH01

ATC

celecoxib; oral

2.1

124.0

1475

7936

ZXA05

NOMESCO Finland

Left side

2.0

123.2

1909

11289

WX212

NOMESCO Finland

Femoral plexus blockade

4.4

122.8

319

754

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

5.3

122.2

254

499

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

18.1

121.7

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.1

121.5

555

1913

A01

ICPC

Pain general/multiple sites

2.4

120.4

937

4233

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

5.8

120.2

222

391

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

117.8

998

4676

A02BC02

ATC

pantoprazole; systemic

1.9

117.4

4920

39465

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

113.9

2030

12517

N02BE01

ATC

paracetamol; systemic, rectal

2.8

113.0

6205

54608

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.3

111.8

228

440

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.2

111.3

470

1545

M03BC01

ATC

orphenadrine (citrate); systemic

2.0

110.7

1670

9730

M01AB05

ATC

diclofenac; systemic, rectal

1.8

109.3

4605

36529

R4110

NOMESCO Finland

Physiotherapy

1.9

109.0

2106

13285

L13

ICPC

Hip symptom/complaint

2.0

108.5

1602

9256

N06AX11

ATC

mirtazapine; oral

1.8

108.4

2518

16793

WX002

NOMESCO Finland

Sedation and analgesia

2.0

107.5

1513

8596

A02BC05

ATC

esomeprazole; systemic

1.8

106.5

2975

20902

SPAT1153

SPAT

Removal of sutures

1.8

103.5

2331

15353

M25.5

ICD-10 Finland

Pain in joint

1.8

103.5

2429

16194

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

102.1

1747

10566

ZXA00

NOMESCO Finland

Right side

1.8

102.0

1964

12329

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.2

101.5

415

1337

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

101.2

2908

20503

N03AE01

ATC

clonazepam; systemic

2.8

100.8

537

2010

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

100.5

1480

8514

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

99.7

2591

17738

Z3226

NOMESCO Finland

Physiotherapist

2.0

99.4

1374

7733

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

10.6

98.8

108

103

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

4.4

98.6

250

579

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.1

98.6

425

1413

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

4.4

98.4

250

580

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.2

98.4

966

4787

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

7.3

98.1

144

200

H02AB06

ATC

prednisolone; systemic

1.7

97.9

3392

25096

J01DB01

ATC

cefalexin; oral

2.0

97.5

5647

48455

X58

ICD-10 Finland

Exposure to other specified factors

2.1

97.4

1139

6034

N06AX16

ATC

venlafaxine; oral

2.1

96.7

1067

5530

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

10.2

96.2

108

107

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

95.3

3456

25812

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

95.2

4850

39757

A28

ICPC

Limited function/disability NOS

1.9

94.7

1450

8431

JAG96

NOMESCO Finland

Other reconstruction of abdominal wall

24.7

93.5

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

4.8

93.3

213

453

N05CF01

ATC

zopiclone; oral

1.7

92.8

2338

15786

R06.0

ICD-10 Finland

Dyspnoea

1.8

92.0

2027

13169

WX702

NOMESCO Finland

Supraglottic ventilation device

2.7

91.7

523

2026

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

8.8

91.3

115

133

M95.8

ICD-10 Finland

Other specified acquired deformities of musculoskeletal system

900.7

91.0

NHG22

NOMESCO Finland

Fusion of subtalar joint

8.1

90.2

122

154

ZZH40

NOMESCO Finland

Substitute of bone

6.6

89.4

144

221

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

89.4

1107

5971

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.2

89.4

827

3992

J01FF01

ATC

clindamycin; systemic

1.8

89.3

1952

12632

A02BC03

ATC

lansoprazole; oral

1.7

88.5

2078

13718

AA1AD

NOMESCO Finland

CT of head and brain

1.7

88.3

2170

14507

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.3

88.2

712

3246

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

87.1

2048

13510

WX720

NOMESCO Finland

Own respiration

2.8

86.1

463

1738

A02BC01

ATC

omeprazole; systemic

1.7

86.1

1975

12933

N05BA01

ATC

diazepam; systemic, rectal

2.1

85.7

1000

5273

WX214

NOMESCO Finland

Plexus blockade at the ankle

8.8

85.7

108

125

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

85.3

612

2645

M01AH02

ATC

rofecoxib; oral

2.0

84.6

996

5268

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

18.1

84.5

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

84.3

392

1359

L08

ICPC

Shoulder symptom/complaint

1.8

84.2

1749

11120

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

84.0

1693

10668

R03AC02

ATC

salbutamol; inhalant

1.6

83.8

3705

28732

NF3AD

NOMESCO Finland

Femur CT

12.8

83.7

M01AC06

ATC

meloxicam; systemic, rectal

1.7

83.3

2565

18144

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.7

83.2

272

758

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

83.1

4377

35454

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

82.6

1245

7166

NHG20

NOMESCO Finland

Fusion of talocrural joint

7.9

82.4

113

145

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.9

81.3

1169

6620

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.7

81.0

450

1717

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

80.6

621

2769

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

79.9

949

5027

NAG67

NOMESCO Finland

Posterior interbody fusion of lumbar spine, more than 2 vertebrae

36.0

79.8

ZXD05

NOMESCO Finland

Urgent procedure

1.7

79.7

2028

13608

M01AE02

ATC

naproxen; oral, rectal

1.6

79.4

3733

29224

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.7

78.7

448

1731

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

6.9

78.6

122

180

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

78.3

1062

5890

NFH30

NOMESCO Finland

Reduction of dislocation prosthesis of hip joint, closed

7.8

78.1

108

140

NGC30

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, special prosthesis

7.2

77.8

115

161

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.2

77.2

322

1048

ZXE00

NOMESCO Finland

One hour or less

1.6

76.6

2572

18491

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

4.8

76.4

176

377

M01AB55

ATC

diclofenac, combinations; oral

2.4

76.3

566

2480

2309

FHL

Other measure in this category

32.9

76.2

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.1

75.6

333

1119

M53.2

ICD-10 Finland

Spinal instabilities

6.8

75.3

118

176

M01AX17

ATC

nimesulide; oral

1.7

75.2

1723

11204

M96.9

ICD-10 Finland

Postprocedural musculoskeletal disorder, unspecified

117.1

75.0

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

74.8

2081

14247

TAB20

NOMESCO Finland

Epidural puncture

6.4

74.4

123

194

M54.2

ICD-10 Finland

Cervicalgia

2.2

74.3

654

3083

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

73.6

586

2647

J01MA02

ATC

ciprofloxacin; systemic

1.6

73.6

2688

19674

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.7

73.2

404

1535

7397A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Upper extremities

+∞

73.0

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

6.1

73.0

127

211

NF1DA

NOMESCO Finland

X-ray of hips

3.7

72.6

234

646

L15

ICPC

Knee symptom/complaint

1.7

72.4

1824

12147

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

10.2

72.3

1220

FHL

Arthroscopy

2.9

72.0

353

1259

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

12.4

71.8

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

5.1

71.6

151

300

WX308

NOMESCO Finland

Sacral anesthesy

11.1

71.0

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

70.7

2050

14142

R52.1

ICD-10 Finland

Chronic intractable pain

5.9

70.4

128

222

A06AD11

ATC

lactulose; oral

1.9

70.0

1090

6306

N05AH04

ATC

quetiapine; oral

1.8

69.4

1190

7094

R02

ICPC

Shortness of breath/dyspnoea

1.9

69.0

1035

5915

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.9

68.7

207

545

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

68.7

1385

8657

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

7.3

68.5

100

138

7225B

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]

11.6

68.0

M41.9

ICD-10 Finland

Scoliosis, unspecified

4.8

67.9

153

322

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.4

67.8

249

749

L12

ICPC

Hand/finger symptom/complaint

1.8

67.5

1240

7539

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

67.2

2521

18454

R5110, ,

SPAT

2.1

67.0

715

3629

WX400

NOMESCO Finland

Inhalation anesthesy

2.9

66.9

337

1220

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

7.9

66.3

117

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

6.6

66.2

107

165

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.1

66.1

287

956

WZA00

NOMESCO Finland

Concise certificate

2.3

65.8

508

2261

N05BA04

ATC

oxazepam; oral

1.6

65.6

1801

12208

M02AA07

ATC

piroxicam; topical

1.6

65.3

2456

17958

NH1AD

NOMESCO Finland

Ankle and foot CT

3.5

65.3

234

693

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.5

64.8

436

1824

J04AB02

ATC

rifampicin; systemic

4.7

64.7

150

323

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.9

64.7

326

1180

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

64.5

629

3082

L02

ICPC

Back symptom/complaint

2.0

64.0

750

3935

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.5

63.6

417

1723

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.6

63.5

383

1520

M54.8

ICD-10 Finland

Other dorsalgia

2.6

63.2

386

1542

N06AA10

ATC

nortriptyline; systemic

3.7

63.2

203

559

R52.9

ICD-10 Finland

Pain, unspecified

2.0

63.0

786

4215

J01DA01

ATC

[U] cefalexin

1.5

62.9

4021

32964

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

4.7

62.9

146

315

N03AX09

ATC

lamotrigine; oral

2.7

62.7

347

1319

M01AX01

ATC

nabumetone; oral

2.7

62.7

353

1354

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.9

62.4

297

1042

NHG26

NOMESCO Finland

Fusion between bones of ankle or ankle and foot

4.8

62.2

142

302

G83.4

ICD-10 Finland

Cauda equina syndrome

9.2

62.2

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.4

62.1

230

695

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

61.9

3604

28910

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

61.7

1861

12875

R51.80

ICD-10 Finland

Headache

1.8

61.6

1067

6359

T84.2

ICD-10 Finland

Mechanical complication of internal fixation device of other bones

16.4

61.6

7380A

ICD-9 Finland

Other acquired deformity, Acquired deformity of nose

+∞

61.5

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

61.5

1345

8567

NG1DA

NOMESCO Finland

X-ray of knees

3.7

61.1

196

539

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.3

60.9

160

381

ACC51

NOMESCO Finland

Release of median nerve

2.2

60.9

587

2862

N05CF02

ATC

zolpidem; oral

1.8

60.7

1198

7412

C03CA01

ATC

furosemide; systemic

1.6

60.7

2089

14903

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

60.6

4638

39405

QBJ30

NOMESCO Finland

Correction of abdominal apron

6.3

60.2

102

165

SPAT1229

SPAT

Assessment of need for aid

2.1

59.5

590

2906

W19

ICD-10 Finland

Unspecified fall

2.0

59.2

735

3931

N05CD07

ATC

temazepam; oral

1.9

58.8

831

4641

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

58.8

390

1620

NFC00

NOMESCO Finland

Exchange of a loose part of prosthesis in hip joint

7.1

58.7

125

R60.0

ICD-10 Finland

Localized oedema

1.8

58.6

958

5603

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.2

58.5

516

2426

S72.4

ICD-10 Finland

Fracture of lower end of femur

5.7

58.5

110

197

L04AA13

ATC

[U] leflunomide

3.3

58.4

229

717

S72.8

ICD-10 Finland

Fractures of other parts of femur

10.2

58.1

R4110, ,

SPAT

1.8

58.0

1007

5997

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

2.6

57.8

347

1374

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

57.7

1541

10318

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

57.7

1492

9911

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.7

57.3

313

1181

N07BC02

ATC

methadone; systemic

8.8

57.3

DHD10

NOMESCO Finland

Closed reduction of fracture of nose

7.3

57.1

117

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.0

56.8

254

860

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

56.6

834

4718

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.2

56.5

537

2600

M01AE01

ATC

ibuprofen; systemic, rectal

1.8

56.5

5914

53727

R53

ICD-10 Finland

Malaise and fatigue

1.6

56.4

1713

11829

M01AB51

ATC

indometacin, combinations; oral, rectal

3.4

56.3

210

638

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.2

56.0

501

2369

Z01.2

ICD-10 Finland

Dental examination

1.5

55.8

2975

23228

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

55.7

1767

12321

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

8.3

55.6

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.3

55.3

208

635

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.2

55.3

225

721

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

7.6

55.1

104

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

5.1

55.0

115

227

L01BA01

ATC

methotrexate; systemic

2.7

54.9

302

1144

A02BA02

ATC

ranitidine; systemic

1.7

54.2

1320

8616

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.0

53.2

237

801

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

4.0

53.1

155

399

Z71.8

ICD-10 Finland

Other specified counselling

1.5

53.0

2209

16331

M01AX05

ATC

glucosamine; oral

1.6

53.0

1366

9042

NAW10

NOMESCO Finland

Reoperation for superficial infection in in surgery of spine or neck

16.2

52.9

J01AA02

ATC

doxycycline; systemic

1.6

52.9

5148

45306

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

5.8

52.8

170

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

14.8

52.8

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

52.6

613

3201

M19.2

ICD-10 Finland

Other secondary arthrosis

4.2

52.2

141

343

7385A

ICD-9 Finland

Other acquired deformity of back or spine

+∞

52.1

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

51.5

2325

17455

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

6.1

51.5

147

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

51.4

787

4499

Z98.1

ICD-10 Finland

Arthrodesis status

20.6

51.3

SPAT1301

SPAT

No procedures

1.5

51.1

2025

14786

Z3231

NOMESCO Finland

Registered nurse

1.6

51.1

1773

12575

R4120

NOMESCO Finland

Occupational therapy

2.1

51.1

488

2366

NHG82

NOMESCO Finland

Fusion of other tarsal joint

4.7

50.7

118

255

N02AJ13

ATC

tramadol and paracetamol; systemic

3.1

50.6

213

696

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

4.1

50.5

139

343

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

5.6

50.3

171

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

50.0

461

2204

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

49.7

1854

13345

M54

ICD-10 Finland

Dorsalgia

1.8

49.6

839

4941

B01AB04

ATC

dalteparin; parenteral

2.3

49.6

391

1753

K02.1

ICD-10 Finland

Caries of dentine

1.5

49.5

3692

30527

R42

ICD-10 Finland

Dizziness and giddiness

1.6

49.4

1598

11141

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.5

49.3

170

491

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.8

49.0

254

933

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

48.9

2427

18527

S73.0

ICD-10 Finland

Dislocation of hip

5.9

48.9

148

ZXD20

NOMESCO Finland

Day surgery

1.8

48.8

854

5079

SFA10

NOMESCO Finland

One-surface restoration

1.5

48.7

3485

28551

R05

ICPC

Cough

1.6

48.1

1645

11603

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

47.9

797

4667

N06AB03

ATC

fluoxetine; oral

1.8

47.8

800

4693

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

47.8

672

3735

75618

ICD-8 Finland

Other congenital anomalies of musculoskeletal system, Maleformationes columnae vertebralis aliae

8.9

47.5

M50.3

ICD-10 Finland

Other cervical disc degeneration

3.0

47.4

213

723

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

4.9

47.4

105

218

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.7

47.3

259

978

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

47.2

231

822

UJF32

NOMESCO Finland

Coloscopy

1.5

47.2

1769

12719

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

47.2

517

2638

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

4.0

47.0

136

348

SPAT1263

SPAT

Sampling

1.5

46.9

2621

20429

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

9.1

46.8

L89

ICPC

Osteoarthrosis of hip

2.4

46.8

319

1340

M99.4

ICD-10 Finland

Connective tissue stenosis of neural canal

125.9

46.8

L88

ICPC

Rheumatoid/seropositive arthritis

2.4

46.6

332

1423

N06AB04

ATC

citalopram; systemic

1.6

46.5

1350

9162

J01EA01

ATC

trimethoprim; systemic

1.5

46.0

1667

11887

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

46.0

2910

23199

DHB50

NOMESCO Finland

Turbinoplasty

3.0

45.9

206

699

S97

ICPC

Chronic ulcer skin

2.1

45.8

473

2361

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.0

45.7

202

679

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

45.5

369

1673

M03BX01

ATC

baclofen; systemic

3.3

45.5

170

517

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.3

45.5

379

1738

J01FA06

ATC

roxithromycin; oral

1.5

45.3

2541

19782

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

3.5

45.3

158

460

RF210, ,

NOMESCO Finland

2.8

45.1

225

809

A46

ICD-10 Finland

Erysipelas

1.7

45.1

1028

6566

M79.7

ICD-10 Finland

Fibromyalgia

2.6

45.0

272

1079

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

45.0

1149

7552

R01AD09

ATC

mometasone; nasal

1.4

45.0

2830

22506

L75

ICPC

Fracture: femur

3.9

44.9

133

346

R06AE07

ATC

cetirizine; oral

1.4

44.8

2761

21866

C07AB07

ATC

bisoprolol; oral

1.4

44.6

3233

26372

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

44.5

2867

22883

N04BC05

ATC

pramipexole; oral

2.0

44.4

553

2949

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

4.3

44.2

114

268

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

44.1

745

4376

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

44.1

3285

26906

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.5

43.8

277

1123

G04BD12

ATC

mirabegron; oral

1.7

43.4

868

5350

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

43.0

787

4730

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

3.9

43.0

127

330

SPAT1260

SPAT

Consultation of another employee

1.6

42.7

1125

7443

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.5

42.5

264

1062

J02AC01

ATC

fluconazole; systemic

1.4

42.5

2403

18677

TQW40, ,

SPAT

1.8

42.3

714

4193

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

42.2

887

5538

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.2

42.1

393

1885

WX290

NOMESCO Finland

Other blockage of nerve

1.4

42.1

2839

22771

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

42.0

350

1604

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

42.0

431

2144

G44.2

ICD-10 Finland

Tension-type headache

1.7

41.8

878

5480

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

41.7

239

924

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

5.9

41.7

129

S70.0

ICD-10 Finland

Contusion of hip

2.3

41.6

311

1362

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

41.5

1197

8085

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

41.3

683

3983

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.0

41.3

467

2407

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.7

41.1

228

867

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

10.5

41.1

S21

ICPC

Skin texture symptom/complaint

1.6

41.0

1038

6792

S06.0

ICD-10 Finland

Concussion

1.8

40.8

707

4180

M79.1

ICD-10 Finland

Myalgia

1.6

40.8

969

6241

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

14.3

40.8

R96

ICPC

Asthma

1.8

40.7

697

4106

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.0

40.7

449

2293

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

40.7

1059

6977

S72.2

ICD-10 Finland

Subtrochanteric fracture

5.1

40.6

168

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

40.6

503

2675

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

6.0

40.5

119

P03

ICPC

Feeling depressed

1.9

40.5

578

3222

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

40.5

535

2909

XA402

NOMESCO Finland

ENMG

2.8

40.3

207

756

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.2

40.3

349

1625

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

40.2

856

5359

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

40.1

492

2608

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

5.5

40.1

141

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

39.9

889

5629

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

5.9

39.8

121

NG1AD

NOMESCO Finland

Knee CT examination

3.3

39.6

153

475

M54.6

ICD-10 Finland

Pain in thoracic spine

1.9

39.6

499

2669

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

4.8

39.6

191

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

39.5

2352

18385

J01MA12

ATC

levofloxacin; systemic

1.6

39.5

1205

8234

L29

ICPC

Musculoskeletal sympt/complt other

1.8

39.4

630

3636

L14

ICPC

Leg/thigh symptom/complaint

1.9

39.3

576

3236

L16

ICPC

Ankle symptom/complaint

1.7

39.3

794

4900

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.7

39.3

758

4619

ZXA10

NOMESCO Finland

Bilateral

1.6

39.2

1193

8145

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

39.0

1238

8533

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

39.0

1658

12154

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

4.8

38.9

186

A04

ICPC

Weakness/tiredness general

1.6

38.9

1032

6824

A97

ICPC

No disease

1.5

38.9

1295

9022

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.6

38.7

224

870

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.9

38.7

182

634

WW502

NOMESCO Finland

Autotransfusion

5.0

38.7

164

U02

ICPC

Urinary frequency/urgency

1.6

38.6

990

6491

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

38.5

1176

8032

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

4.2

38.5

104

253

Z50.1

ICD-10 Finland

Other physical therapy

2.1

38.5

384

1889

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

38.3

321

1474

P01AB01

ATC

metronidazole; oral, rectal

1.4

38.3

2482

19666

G47.3

ICD-10 Finland

Sleep apnoea

1.5

38.3

1491

10731

L04AX03

ATC

methotrexate; systemic

1.8

38.3

649

3811

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

38.1

1112

7515

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

37.9

483

2592

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

37.9

1242

8614

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

37.9

405

2045

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.5

37.8

249

1029

R35

ICD-10 Finland

Polyuria

1.9

37.8

487

2623

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

37.8

688

4121

-1, ,

NOMESCO Finland

1.4

37.8

1954

14858

WX213

NOMESCO Finland

Lower leg blockade

4.5

37.7

211

P01BA02

ATC

hydroxychloroquine; oral

1.8

37.7

561

3167

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

37.7

1569

11443

SFA20

NOMESCO Finland

Two-surface restoration

1.4

37.6

3631

30754

L01

ICPC

Neck symptom/complaint

1.6

37.5

1052

7042

N06AB10

ATC

escitalopram; oral

1.5

37.5

1194

8228

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

37.4

1468

10577

NH1AI

NOMESCO Finland

Cone beam CT of ankle

6.8

37.3

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

37.2

528

2936

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

37.1

1718

12787

M01AH03

ATC

valdecoxib; oral

2.0

36.8

425

2206

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

36.7

903

5855

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

36.7

501

2751

XKD00

NOMESCO Finland

Uroflowmetry

1.6

36.7

971

6411

R1100, ,

SPAT

3.4

36.6

132

393

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

36.4

2670

21558

RF120, ,

NOMESCO Finland

3.9

36.4

106

273

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

36.3

1841

13925

N03A

ATC

ANTIEPILEPTICS

11.2

36.2

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

5.3

36.1

140

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

4.4

36.1

206

M20.2

ICD-10 Finland

Hallux rigidus

2.5

36.1

242

1009

XKC03

NOMESCO Finland

Water cystometry

2.5

36.0

234

961

M01CB01

ATC

sodium aurothiomalate; parenteral

3.7

35.9

116

321

M95.9

ICD-10 Finland

Acquired deformity of musculoskeletal system, unspecified

80.6

35.8

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

35.8

646

3859

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

5.8

35.7

113

M01AE51

ATC

ibuprofen, combinations; systemic

3.3

35.7

138

429

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

35.7

513

2863

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

35.6

509

2835

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

35.6

195

737

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.8

35.6

182

664

KMAK, ,

NOMESCO Finland

1.4

35.5

3079

25522

C07AA05

ATC

propranolol; systemic

1.5

35.3

1203

8401

N01

ICPC

Headache

1.7

35.1

638

3818

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

35.1

506

2827

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.2

35.0

320

1522

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

35.0

517

2909

N06AX03

ATC

mianserin; oral

2.1

35.0

331

1596

NAG60

NOMESCO Finland

Anterior fusion of lumbar spine with fixation

43.2

34.9

L84

ICPC

Back syndrome without radiat pain

2.1

34.9

350

1725

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.7

34.8

743

4644

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

34.7

878

5728

Z2221

NOMESCO Finland

Medical doctor

1.5

34.6

1638

12212

N05AA02

ATC

levomepromazine; systemic

2.3

34.6

265

1172

UKC02

NOMESCO Finland

Cystoscopy

1.6

34.6

1018

6882

TAC99

NOMESCO Finland

Other blockade for chronic pain

5.1

34.5

142

J01CA04

ATC

amoxicillin; systemic

1.5

34.5

5167

46804

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

34.5

373

1891

R52.0

ICD-10 Finland

Acute pain

2.4

34.4

238

1006

G04CA02

ATC

tamsulosin; oral

1.5

34.3

1391

10063

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.9

34.2

497

2781

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.9

34.1

165

584

NFU00

NOMESCO Finland

Removal of partial prosthesis from hip joint, other or unspecified

13.4

33.9

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

33.9

275

1246

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

33.9

1806

13752

NDG30

NOMESCO Finland

Fusion of wrist, total

5.7

33.9

112

NA2AD

NOMESCO Finland

Thoracic spine CT examination

4.8

33.8

160

SPAT1216

SPAT

Assessment of functional ability

1.6

33.8

997

6739

SPAT1202

SPAT

Intra-articular injection

2.4

33.8

230

966

B01AB10

ATC

tinzaparin; parenteral

1.7

33.6

731

4589

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

33.6

516

2939

D01

ICPC

Abdominal pain/cramps general

1.6

33.5

766

4871

S29

ICPC

Skin symptom/complaint other

1.5

33.4

1323

9518

M09AX01

ATC

hyaluronic acid; parenteral

2.1

33.4

345

1720

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.7

33.3

596

3548

NFC99

NOMESCO Finland

Other secondary prosthetic replacement in hip joint, other or unspecified

9.0

33.3

R21

ICPC

Throat symptom/complaint

1.5

33.2

1138

7948

P06

ICPC

Sleep disturbance

1.6

33.2

810

5235

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.7

33.1

176

655

J01XX08

ATC

linezolid; systemic

4.8

33.1

155

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

3.4

33.1

119

354

A03FA02

ATC

cisapride; oral, rectal

1.8

33.0

488

2746

A01AB09

ATC

miconazole; local oral

1.8

33.0

547

3186

J01DA09

ATC

[U] cefadroxil

1.4

32.8

1591

11895

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.5

32.8

203

815

E0000UV, ,

ATC

1.4

32.7

2572

20896

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

32.6

377

1956

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

32.6

4054

35375

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

32.5

841

5511

M48.9

ICD-10 Finland

Spondylopathy, unspecified

5.2

32.5

131

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.1

32.4

325

1601

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

32.2

965

6539

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.3

32.2

246

1087

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

32.1

461

2569

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

4.1

32.1

217

U07

ICPC

Urine symptom/complaint other

1.7

32.0

581

3473

J01FA10

ATC

azithromycin; systemic

1.4

31.8

3427

29198

K30

ICD-10 Finland

Functional dyspepsia

1.6

31.7

729

4638

R01AD08

ATC

fluticasone; nasal

1.4

31.7

1707

12997

D07AC01

ATC

betamethasone; topical

1.4

31.5

2288

18319

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.3

31.5

238

1047

B01AX06

ATC

[U] rivaroxaban

2.6

31.4

178

685

N02AA03

ATC

hydromorphone; systemic, rectal

7.6

31.4

SFA30

NOMESCO Finland

Three-surface restoration

1.4

31.3

2640

21637

7392A

ICD-9 Finland

Nonallopathic lesions, not elsewhere classified, Thoracic region

+∞

31.3

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

31.2

429

2358

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.4

31.2

228

989

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

31.1

433

2391

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

8.7

31.0

D11

ICPC

Diarrhoea

1.6

31.0

719

4585

A29

ICPC

General symptom/complaint other

1.6

31.0

894

6005

M02AA10

ATC

ketoprofen; topical

1.5

30.9

1020

7054

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

30.9

771

5003

G04BD08

ATC

solifenacin; oral

1.8

30.9

448

2504

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.9

30.9

145

505

NB1AD

NOMESCO Finland

Shoulder CT examination

2.9

30.9

147

516

M99.7

ICD-10 Finland

Connective tissue and disc stenosis of intervertebral foramina

314.4

30.8

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

3.6

30.8

103

292

T84.68

ICD-10 Finland

Infection and inflammatory reaction due to internal fixation device [any site]

12.0

30.7

ZZH20

NOMESCO Finland

Graft of patients own bone

6.5

30.6

N30.0

ICD-10 Finland

Acute cystitis

1.5

30.6

1087

7635

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

30.5

475

2713

D06

ICPC

Abdominal pain localized other

1.7

30.5

570

3434

L99

ICPC

Musculoskeletal disease other

2.6

30.4

176

684

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

30.4

867

5805

B01AF01

ATC

rivaroxaban; oral

1.6

30.3

850

5672

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

30.2

258

1194

NAK30

NOMESCO Finland

Osteotomy of spine

38.2

30.2

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

3.4

30.2

110

330

M41.5

ICD-10 Finland

Other secondary scoliosis

7.7

30.1

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

30.1

253

1164

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.0

30.1

358

1876

D12

ICPC

Constipation

2.2

30.0

270

1276

T84.3

ICD-10 Finland

Mechanical complication of other bone devices, implants and grafts

11.5

30.0

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.3

30.0

239

1075

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

30.0

824

5470

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

29.9

272

1291

J01FA09

ATC

clarithromycin; systemic

1.4

29.8

1868

14567

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

6.4

29.8

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.3

29.8

239

1078

R33

ICD-10 Finland

Retention of urine

1.8

29.7

504

2953

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

29.6

615

3810

RF220, ,

NOMESCO Finland

3.3

29.6

112

344

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

3.6

29.6

267

A11

ICPC

Chest pain NOS

1.7

29.4

589

3613

M41.8

ICD-10 Finland

Other forms of scoliosis

4.8

29.1

140

N06AA12

ATC

doxepin; systemic

2.0

29.1

335

1736

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

29.0

1220

8855

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.1

28.9

124

411

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.4

28.8

200

848

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

28.7

292

1446

R03DC03

ATC

montelukast; oral

1.5

28.7

1004

7021

9165

FHL

Removal of osteosynthesis material

2.7

28.7

150

554

R03BA02

ATC

budesonide; inhalant

1.5

28.6

1079

7662

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

28.6

520

3108

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.7

28.5

159

607

WVA20, ,

SPAT

2.2

28.5

259

1230

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

3.0

28.4

128

436

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.7

28.4

148

546

M89.0

ICD-10 Finland

Algoneurodystrophy

4.1

28.3

193

N03AF01

ATC

carbamazepine; oral, rectal

2.0

28.3

322

1661

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.8

28.1

474

2772

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

4.3

28.1

173

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

4.9

28.1

125

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

28.0

1137

8191

A08

ICPC

Swelling

1.8

27.9

401

2236

UJD02

NOMESCO Finland

Gastroscopy

2.0

27.8

316

1630

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4041

28377

2.06

174.18

3.6

2.8

—

estimate

—

(3042936) Bacteria identified in Isolate by Culture

1690

8895

2.20

154.75

2.9

2.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1304

6312

2.32

145.17

8.8

8.6

119.08

120.95

g/l

2.60

1269

6163

(3019977) pH of Arterial blood

1467

7609

2.19

137.27

8.4

7.8

7.41

7.42

1.28

804

4204

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1465

7611

2.18

136.43

8.3

7.7

5.17

5.10

kpa

2.38

1409

7320

(3027801) Oxygen [Partial pressure] in Arterial blood

1463

7607

2.18

135.89

8.3

7.7

12.80

12.32

kpa

2.61

1409

7315

(3003396) Base excess in Arterial blood by calculation

1455

7560

2.18

135.33

8.3

7.7

1.05

0.97

mmol/l

0.34

1223

6210

(3013826) Glucose [Moles/volume] in Serum or Plasma

4677

36312

1.95

131.46

6.6

5.2

6.65

6.74

mmol/l

2.07

4505

34539

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

880

3755

2.55

128.43

8.8

10.2

15.87

15.94

0.32

845

3620

(3016502) Oxygen saturation in Arterial blood

1325

6779

2.19

127.29

8.5

8.1

96.22

95.60

4.01

1280

6538

(3024561) Albumin [Mass/volume] in Serum or Plasma

3802

28419

1.78

111.48

5.9

5.2

35.04

35.51

g/l

5.57

3576

26642

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3805

28499

1.77

110.27

7.9

6.7

1.20

1.21

mmol/l

9.90

3602

26389

(3031040) Bacteria [#/volume] in Urine by Automated count

4880

39537

1.86

106.46

6.5

4.9

791.67

2032.66

e6/l

1.76

546

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5346

44633

1.97

105.90

6.2

4.5

12.91

12.59

mm/h

0.84

5089

41815

(3032080) INR in Blood by Coagulation assay

3853

29222

1.75

104.28

14.4

15.7

1.21

1.27

inr

11.47

3271

24453

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4112

31874

1.75

101.86

8.8

7.5

1.21

mmol/l

8.04

3638

27572

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

410

1350

3.17

96.62

2.4

1.6

—

(3018418) pH of Serum or Plasma

2734

19305

1.70

91.93

4.5

4.4

7.40

0.18

1977

13928

(3007853) Bacteria identified in Skin by Aerobe culture

1297

7337

1.95

91.59

2.0

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4950

41088

1.78

89.82

6.3

4.8

1.39

2.46

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5455

46734

1.89

87.80

9.7

8.5

79.54

79.51

u/l

0.01

5257

44417

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1923

12447

1.76

87.57

5.1

4.0

239.56

464.08

ng/l

1.67

1550

9906

(3035350) Ketones [Presence] in Urine by Test strip

4102

32458

1.68

87.46

4.9

4.1

3.40

4.36

estimate

0.15

834

6874

(3009261) Glucose [Presence] in Urine by Test strip

4119

32660

1.68

86.81

4.9

4.1

0.00

0.22

estimate

0.77

798

6443

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4124

32786

1.67

85.29

6.5

6.8

10.89

11.55

umol/l

3.77

3970

31322

(3023368) Bacteria identified in Blood by Culture

2516

17648

1.68

84.84

5.4

4.5

—

(3013115) Eosinophils [#/volume] in Blood

4060

32170

1.66

84.84

7.8

6.6

0.20

0.19

e9/l

0.59

3598

27984

(3008152) Bicarbonate [Moles/volume] in Arterial blood

819

4029

2.18

84.17

7.9

6.9

24.90

24.54

mmol/l

2.19

785

3850

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1298

7558

1.89

83.12

2.2

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1701

10772

1.78

82.74

2.2

1.9

—

(3006315) Basophils [#/volume] in Blood

3955

31235

1.65

82.73

7.6

6.4

0.04

e9/l

0.24

3452

26700

(3006504) Eosinophils/Leukocytes in Blood

3685

28613

1.64

82.31

7.7

6.6

2.86

2.85

0.12

3491

26756

(3001604) Monocytes [#/volume] in Blood

3943

31147

1.64

82.12

7.7

6.3

0.60

0.59

e9/l

0.69

3434

26618

(3022096) Basophils/Leukocytes in Blood

3684

28616

1.64

82.05

7.8

6.7

0.66

0.68

1.64

3491

26736

(3019069) Monocytes/Leukocytes in Blood

3692

28696

1.64

82.00

7.8

6.7

8.89

8.93

0.37

3504

26852

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1362

8085

1.86

81.97

2.2

1.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

4036

32089

1.65

81.72

4.8

4.1

0.00

estimate

1.34

809

6691

(3047181) Lactate [Moles/volume] in Blood

490

1948

2.63

81.35

6.5

6.2

1.22

1.31

mmol/l

1.59

445

1718

(3019198) Lymphocytes [#/volume] in Blood

4003

31803

1.64

80.91

7.7

6.4

1.87

1.89

e9/l

0.55

3565

27866

(3039000) Anion gap in Blood by calculation

384

1359

2.94

79.57

7.0

7.3

10.86

11.30

mmol/l

1.73

348

1217

(3018572) Chloride [Moles/volume] in Blood

384

1360

2.93

79.46

7.0

7.3

105.32

105.01

mmol/l

0.62

348

1219

(3044640) Blood type and Crossmatch panel - Blood

2745

19955

1.64

78.82

3.0

2.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2726

19836

1.63

77.62

2.7

2.2

223.16

213.70

u/l

0.17

2607

18759

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

295

907

3.36

77.61

7.7

6.5

12.40

12.06

mg/l

0.62

282

851

(3026008) Bacteria identified in Urine by Culture

2662

19295

1.63

76.75

4.3

3.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2341

16450

1.65

76.32

2.7

2.4

2.67

2.85

mg/l

3.35

2070

14232

(3002030) Lymphocytes/Leukocytes in Blood

3719

29276

1.61

75.73

7.8

6.6

27.23

27.36

0.32

3557

27679

(3018010) Neutrophils/Leukocytes in Blood

3660

28736

1.60

75.07

7.7

6.5

57.81

57.60

0.51

3523

27402

(3013650) Neutrophils [#/volume] in Blood by Automated count

4276

34905

1.62

74.05

10.2

9.8

4.24

4.14

e9/l

1.81

3742

30222

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2716

19945

1.61

73.19

3.1

2.7

53.82

64.44

u/l

2.00

2549

18533

(3015736) pH of Urine

3329

25833

1.57

69.64

4.1

3.6

6.22

6.23

0.05

1758

14449

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1719

11377

1.69

69.32

1.4

1.3

32.02

31.64

iu/ml

0.04

573

3463

(3021960) Folate [Moles/volume] in Serum or Plasma

2500

18228

1.59

68.01

1.9

1.7

20.46

20.27

nmol/l

0.17

2195

15427

(3044889) 12 lead EKG panel

4917

42027

1.63

65.94

5.1

4.2

0.27

4682.60

0.68

(3022948) Iron [Moles/volume] in Serum or Plasma

1654

10974

1.67

65.46

2.7

12.14

12.83

umol/l

3.65

1562

10223

(3002582) Erythrocytes [#/volume] in Urine

2731

20522

1.56

64.01

4.2

3.5

53.98

73.50

e6/l

0.65

2130

15713

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3519

27983

1.54

63.64

3.6

3.1

123.77

133.51

ug/l

1.94

3301

26087

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1599

10582

1.67

63.63

1.4

1.3

11.86

12.19

u/ml

0.06

541

4091

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1559

10269

1.67

63.08

2.7

2.34

2.31

g/l

1.28

1461

9494

(3018095) Leukocytes [#/volume] in Urine

3008

23158

1.54

62.79

5.1

4.1

105.41

102.23

e6/l

0.06

2198

16462

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3516

28010

1.54

62.64

2.5

2.2

94.59

96.29

pmol/l

1.36

1936

14732

(36304419) Bacteria [Presence] in Urine

2315

16853

1.57

61.87

4.0

3.3

2135.12

38.05

estimate

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1944

13626

1.60

60.93

1.9

1.7

1.27

1.29

mg/l

0.12

1611

10653

(3014576) Chloride [Moles/volume] in Serum or Plasma

1380

8941

1.68

58.92

8.4

7.2

104.23

104.30

mmol/l

0.22

1380

8936

(3000475) Leukocytes [#/volume] in Synovial fluid

395

1651

2.48

58.73

1.8

1.6

13602.52

12527.46

e6/l

0.13

269

1155

(3014111) Lactate [Moles/volume] in Serum or Plasma

990

5852

1.81

58.47

8.3

7.6

1.31

1.33

mmol/l

0.27

969

5752

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

596

2988

2.09

57.34

6.2

5.2

1.75

1.60

3.06

558

2829

(3014051) Protein [Presence] in Urine by Test strip

2332

17230

1.54

57.20

3.3

3.0

0.00

0.05

3.45

448

(3000850) Epithelial cells [#/volume] in Urine

2001

14293

1.57

57.08

3.0

2.8

5.77

5.45

e6/l

0.50

1858

13050

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

725

3907

1.96

57.02

9.7

9.6

24.33

24.28

mmol/l

0.18

713

3836

(3006571) Granulocytes/Leukocytes in Synovial fluid

228

724

3.22

56.85

1.8

1.6

55.22

58.43

0.53

148

458

(3033658) Prothrombin time (PT) actual/Normal

2174

15850

1.55

56.48

5.1

4.2

89.97

89.23

0.71

2115

15517

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1432

9476

1.65

55.98

2.7

20.82

22.39

4.57

1350

8804

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2692

20586

1.51

55.84

3.7

3.3

32.94

35.38

u/l

1.05

2575

19418

(3030467) Casts [#/volume] in Urine by Automated count

2381

17753

1.53

55.59

4.1

3.4

0.51

0.43

e6/l

0.60

1795

13072

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6217

57528

2.08

54.59

25.9

17.0

24.11

24.57

mg/l

0.57

5566

47911

(3007930) Methemoglobin/Hemoglobin.total in Blood

554

2757

2.10

54.26

6.4

5.4

0.89

0.88

0.56

518

2607

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1577

10835

1.60

52.38

3.5

3.4

0.81

mmol/l

0.77

1488

10205

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2072

15231

1.52

50.55

2.9

2.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

873

5185

1.79

50.19

3.3

3.0

154.88

198.21

ng/l

3.63

811

4745

(3019150) Specific gravity of Urine by Refractometry

1958

14281

1.52

49.30

5.2

4.3

1.02

1.23

kg/l

0.81

1393

9616

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3435

28085

1.46

48.34

2.8

2.5

78.11

78.20

nmol/l

0.06

3168

25413

(40758558) Short blood count panel - Blood

2435

18664

1.48

47.75

6.8

6.5

—

(3037522) Nuclear Ab [Titer] in Serum

1287

8608

1.61

47.17

1.4

528.56

515.36

titre

0.08

257

1889

(3026493) Urate [Moles/volume] in Serum or Plasma

2203

16588

1.49

47.06

2.8

342.97

344.70

umol/l

0.32

1927

14605

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5142

45735

1.53

45.45

4.9

4.5

14.85

14.83

pmol/l

0.11

4787

42002

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5311

47607

1.55

44.93

31.2

20.9

13.84

13.68

15.14

5271

46982

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2489

19415

1.45

43.40

3.4

3.2

1358.98

1411.34

ng/l

0.23

2176

16790

(3026782) Osmolality of Urine

1674

12075

1.51

43.37

3.1

3.0

519.42

526.42

mosm/kgh2o

0.70

1497

10610

(3000991) Gas panel - Venous blood

897

5580

1.70

43.34

9.8

9.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

377

1765

2.20

42.98

1.6

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6288

59111

2.00

42.13

29.8

20.1

139.47

139.68

mmol/l

9.77

6236

58067

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

785

4756

1.74

41.65

1.8

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1408

9870

1.54

41.40

2.2

2.1

29.84

29.61

0.68

1360

9598

(3023103) Potassium [Moles/volume] in Serum or Plasma

6295

59243

1.99

41.36

30.0

20.3

3.99

3.98

mmol/l

3.02

6241

58096

(3015377) Calcium [Moles/volume] in Serum or Plasma

2749

21997

1.42

40.96

3.2

3.6

2.35

2.36

mmol/l

1.55

2528

19940

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1437

10155

1.53

40.60

3.9

3.2

3.12

2.58

e6/l

0.93

661

4940

(3011397) Hemoglobin [Presence] in Urine by Test strip

1981

14991

1.46

39.71

4.6

3.9

0.25

0.42

—

171

(3025577) Chromium [Mass/volume] in Blood

129

364

3.59

38.79

2.4

2.2

2.14

2.32

ug/l

0.23

111

305

(3026470) Cobalt [Mass/volume] in Blood

131

375

3.54

38.55

2.3

2.2

4.24

3.12

ug/l

0.86

122

346

(3019309) Folate [Moles/volume] in Red Blood Cells

1492

10778

1.49

37.52

1.9

1.8

1170.59

1162.43

nmol/l

0.13

1179

8193

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1539

11193

1.49

37.41

3.7

3.0

1.10

1.08

e6/l

0.04

765

6002

(3036481) Cortisol [Moles/volume] in Serum or Plasma

907

5868

1.63

37.26

2.3

367.38

379.03

nmol/l

0.94

831

5439

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1227

8524

1.54

37.10

5.4

6.2

1.04

mmol/l

0.43

1152

7934

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

694

4203

1.73

36.64

8.9

8.1

24.89

24.88

mmol/l

0.04

688

4181

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

238

4.16

36.42

2.1

2.0

69.58

54.84

ug/l

1.39

232

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1804

13595

1.45

36.31

1.4

1.3

1.48

1.84

u/ml

0.48

446

3682

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5820

53930

1.59

35.72

6.2

5.5

1.83

1.93

mu/l

8.55

5477

49878

(40768797) Stomach Pathology biopsy report

1241

8736

1.52

35.06

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

516

2914

1.83

34.52

1.2

1.1

0.99

1.83

u/ml

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4476

39605

1.39

33.56

3.9

3.4

50.91

49.75

u/l

0.41

4252

37105

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2921

24179

1.37

33.14

4.9

4.1

0.02

0.35

estimate

1.42

671

5496

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1066

7367

1.53

32.60

2.6

2.8

7.47

8.54

umol/l

1.00

920

6469

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

934

6315

1.56

31.46

4.4

3.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1571

11869

1.42

30.22

1.5

2.41

2.50

g/l

0.92

948

7335

(3027945) Reticulocytes/Erythrocytes in Blood

1064

7459

1.51

30.21

2.5

2.6

1.82

1.80

0.25

957

6650

(3009508) Creatinine [Moles/volume] in Urine

2655

21880

1.35

29.99

3.5

7.24

7.40

mmol/l

1.06

2285

18436

(3041096) Erythrocytes [Presence] in Urine by Automated

2141

17067

1.37

29.90

4.1

3.5

0.01

0.20

estimate

1.71

688

5282

(3020630) Protein [Mass/volume] in Serum or Plasma

842

5654

1.56

29.08

2.6

2.7

65.87

66.28

g/l

0.88

777

5168

(3021589) Normoblasts [#/volume] in Blood

3155

26807

1.33

28.51

14.7

11.9

0.00

e9/l

1.69

2559

21811

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2846

23831

1.34

28.38

4.8

3.9

62.51

72.44

ng/l

0.12

2042

17071

(3048689) Calprotectin [Mass/mass] in Stool

1072

7633

1.48

28.00

2.1

2.4

144.55

139.02

ug/g

0.15

871

6092

(3021447) Carbon dioxide [Partial pressure] in Venous blood

936

6546

1.50

26.61

3.7

3.8

5.91

5.81

kpa

2.27

912

6387

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

724

4795

1.57

26.44

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

845

5808

1.52

26.06

2.5

2.6

70.48

69.50

e9/l

0.32

607

4250

(3003329) Lymphocytes/Leukocytes in Synovial fluid

144

552

2.64

25.66

1.8

1.5

29.00

30.63

0.19

333

(36660697) Celiac disease serology panel - Serum

715

4762

1.56

25.43

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

285

3.33

25.42

1.5

3.15

3.57

0.13

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1643

12820

1.37

25.38

2.9

3.1

2.45

2.46

mmol/l

0.30

1453

11492

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

330

1782

1.90

25.34

2.2

1.7

—

(3000494) Fungus identified in Specimen by Culture

1052

7600

1.46

25.27

1.7

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1678

13188

1.36

24.64

1.9

1.7

41768084.50

28069333.53

pmol/l

0.40

1403

10973

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5852

55167

1.47

23.99

7.3

6.6

39.58

39.47

mmol/mol

0.45

5573

51622

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

867

6088

1.49

23.99

2.8

2.5

38.94

47.41

u/l

0.48

736

5146

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

588

3812

1.59

23.43

3.9

24.32

24.25

mmol/l

0.22

583

3774

(3002032) Base excess in Venous blood by calculation

898

6378

1.47

23.43

3.7

3.8

1.81

1.83

mmol/l

0.07

800

5602

(3012544) pH of Venous blood

927

6666

1.45

22.62

3.7

3.8

7.36

7.38

0.68

495

3839

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2958

25428

1.29

22.45

2.0

1.9

1.40

1.36

mmol/l

1.40

2524

21323

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

874

6228

1.46

22.35

2.1

2.2

0.21

g/l

0.13

814

5824

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6356

61173

1.72

22.26

32.0

22.2

77.82

78.33

umol/l

0.55

6321

60493

(3029937) Albumin [Presence] in Urine by Test strip

2165

17883

1.31

22.13

5.4

4.3

0.01

0.00

estimate

0.44

784

6142

(44816559) Phosphatidylethanol [Mass/volume] in Blood

405

2423

1.71

22.09

2.0

1.7

0.28

0.32

mg/l

0.81

210

1144

(3020682) Albumin/Creatinine [Ratio] in Urine

2515

21202

1.30

22.05

4.0

4.2

9.55

8.93

mg/mmol

0.25

1568

13144

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

487

3062

1.64

21.98

1.7

1.57

1.55

g/l

0.13

427

2639

(3012516) Albumin [Mass/volume] in Urine

2475

20854

1.30

21.68

3.4

3.5

50.29

48.56

mg/l

0.13

1603

13249

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

733

5074

1.50

21.64

3.6

3.9

90.77

91.67

ng/l

0.06

652

4352

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1018

7534

1.41

21.11

3.9

4.5

239.11

243.39

u/l

0.55

961

7142

(3003327) Ova and parasites identified in Stool by Light microscopy

350

2040

1.76

20.95

1.7

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

165

3.78

20.47

1.5

1.3

37.62

34.10

0.28

114

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6297

60659

1.61

19.42

15.8

12.7

26.61

26.28

u/l

0.35

6187

58960

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

382

2331

1.68

19.35

2.5

2.3

555.66

641.97

ug/l

0.26

366

2221

(3000570) Elastase.pancreatic [Mass/mass] in Stool

336

1988

1.73

19.08

1.5

1.4

254.35

273.54

ug/g

1.09

218

1187

(3052851) Hemolysis interference index of Serum or Plasma

298

1709

1.78

18.87

3.8

3.3

2.23

2.00

index

0.17

133

884

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

321

1881

1.74

18.86

1.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

376

2301

1.67

18.84

3.2

3.5

31.34

52.76

mg/l

2.35

316

1965

(3034860) Kappa light chains.free [Mass/volume] in Serum

376

2304

1.67

18.75

3.2

3.4

300.23

54.34

mg/l

0.75

317

1969

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

419

2640

1.63

18.72

2.4

2.3

2.92

g/l

0.03

394

2402

(3020779) Urea [Moles/volume] in Serum or Plasma

812

5907

1.43

18.38

6.2

7.7

10.33

10.11

mmol/l

0.35

774

5656

(3005719) IgG [Mass/volume] in Serum or Plasma

688

4859

1.46

18.25

3.0

2.8

9.94

10.60

g/l

4.31

648

4479

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

316

1866

1.73

18.08

1.5

1.7

0.24

g/l

0.64

303

1775

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5884

56030

1.40

18.06

5.8

5.3

5.99

5.96

mmol/l

0.90

5468

51539

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

329

1978

1.70

17.63

2.5

2.3

0.00

g/l

-0.00

288

1738

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

338

2048

1.68

17.59

2.4

2.3

0.05

0.02

g/l

0.67

309

1848

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

487

3236

1.54

17.33

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

903

6776

1.38

16.99

2.0

1.8

1.60

1.48

3.80

791

5930

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

384

2428

1.62

16.92

2.5

2.3

10.06

10.15

g/l

0.17

356

2164

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1186

9297

1.33

16.82

1.6

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

432

2813

1.57

16.81

2.5

2.3

3.87

3.70

g/l

1.02

407

2576

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

432

2816

1.57

16.74

2.5

2.3

7.49

7.43

g/l

0.33

406

2577

(3028026) IgM [Mass/volume] in Serum or Plasma

553

3806

1.49

16.67

2.0

1.30

1.35

g/l

0.15

517

3499

(3009445) Proteinase 3 Ab [Units/volume] in Serum

419

2715

1.58

16.66

1.7

1.6

15.01

17.88

iu/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

431

2816

1.57

16.53

2.5

2.3

4.17

4.21

g/l

0.61

407

2576

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

318

1928

1.68

16.52

1.5

1.7

1.23

1.20

g/l

0.98

305

1837

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

305

1832

1.70

16.41

2.3

2.5

3.75

3.60

g/l

1.03

292

1743

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

330

2034

1.65

16.10

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

380

2430

1.60

15.98

2.5

2.4

0.61

0.90

g/l

1.23

336

2089

(3024928) Oxygen saturation in Venous blood

281

1667

1.72

15.84

2.9

3.1

61.77

61.20

0.16

276

1623

(3023420) DNA double strand Ab [Units/volume] in Serum

394

2559

1.57

15.51

1.7

1.8

5.77

6.70

iu/ml

0.34

623

(46235355) HIV 1 and 2 tests - Meaningful Use set

1143

9020

1.32

15.34

1.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

301

1840

1.67

15.18

2.6

2.3

0.00

g/l

-0.00

288

1735

(3005322) IgE [Units/volume] in Serum or Plasma

549

3847

1.47

15.09

1.4

1.3

204.89

225.93

u/ml

0.27

513

3577

(3011288) Drugs identified in Urine by Screen method Nominal

206

1136

1.84

14.91

3.7

3.0

—

(3017732) Neutrophils [#/volume] in Blood

1017

7927

1.33

14.84

3.3

4.25

4.60

e9/l

1.80

899

6829

(3020191) Ethanol [Moles/volume] in Serum or Plasma

110

483

2.30

14.81

2.4

1.4

1.21

1.17

promille

0.09

388

(3023419) Bacteria identified in Sputum by Culture

163

836

1.97

14.70

2.3

2.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

216

1218

1.80

14.55

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

216

1218

1.80

14.55

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

733

5446

1.39

14.53

3.1

3.2

4.55

4.53

kpa

0.13

713

5300

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

326

2057

1.61

14.50

3.1

3.3

2.02

3.72

ratio

1.76

177

1189

(3008898) HLA-B27 [Presence]

306

1913

1.63

14.14

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

541

3828

1.45

14.12

3.3

3.4

4.47

4.46

pmol/l

0.07

489

3428

(3037756) Immunofixation for Serum or Plasma

238

1402

1.72

13.80

1.8

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

345

2236

1.57

13.72

2.9

2.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

336

2165

1.58

13.70

3.3

3.1

0.35

0.34

iu/ml

0.16

176

1203

(3007461) Platelets [#/volume] in Blood

6389

62188

1.56

13.64

37.8

25.8

252.68

250.03

e9/l

2.52

6308

60980

(3035941) MCH [Entitic mass]

6389

62197

1.56

13.53

37.6

25.7

30.43

30.36

2.18

6357

61554

(3024731) MCV [Entitic mean volume] in Red Blood Cells

6389

62198

1.56

13.52

37.6

25.7

91.64

91.29

7.88

6357

61554

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

6389

62203

1.55

13.45

38.5

26.3

39.86

40.68

4.80

6358

61529

(3026361) Erythrocytes [#/volume] in Blood

6389

62203

1.55

13.45

37.7

25.8

4.40

4.47

e12/l

23.73

6294

60786

(3010813) Leukocytes [#/volume] in Blood

6389

62211

1.55

13.35

37.8

25.8

6.94

6.73

e9/l

5.77

6291

60780

(3000963) Hemoglobin [Mass/volume] in Blood

6389

62213

1.55

13.32

38.0

25.9

132.51

134.79

g/l

28.03

6357

61585

(3015171) Extractable nuclear Ab [Units/volume] in Serum

370

2455

1.54

13.26

1.3

1.2

0.74

1.20

u/ml

0.46

214

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

5073

47836

1.25

13.03

33.3

21.7

331.52

332.03

g/l

3.78

5047

47581

(3017143) Hepatitis C virus Ab [Presence] in Serum

820

6304

1.34

13.03

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

484

3428

1.44

12.56

3.0

2.9

1.40

1.21

3.12

484

3407

(3010144) Erythrocytes [#/volume] in Synovial fluid

125

619

2.04

12.50

1.6

1.4

90687.66

111365.63

e6/l

0.17

421

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

373

2.35

12.44

1.8

1.5

5.42

6.36

u/l

0.70

323

(3045414) Leukocytes [Presence] in Urine

801

6179

1.34

12.42

2.3

2.2

0.04

0.01

estimate

0.50

162

1258

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

581

4262

1.40

12.38

2.5

2.4

18.87

21.65

au/ml

0.43

441

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

189

1076

1.78

12.38

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

392

2684

1.49

12.11

2.3

1.9

2.07

2.29

ug/l

0.13

344

2382

(3004119) Hemoglobin [Mass/volume] in Venous blood

558

4083

1.40

12.07

2.9

3.3

127.82

128.85

g/l

0.48

542

3959

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

539

3922

1.41

12.04

1.4

1.3

35.67

56.52

au/ml

1.72

274

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

344

2296

1.53

12.02

1.4

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

228

1380

1.68

12.00

2.6

2.8

32.49

34.09

umol/l

0.41

200

1257

(3020891) Body temperature

431

3016

1.46

11.93

5.3

4.4

36.90

36.91

°c

0.35

426

2986

(44790049) Parainfluenza type 3 nucleic acid detection

149

800

1.88

11.82

1.7

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

149

800

1.88

11.82

1.7

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

149

800

1.88

11.82

1.7

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

149

800

1.88

11.82

1.7

1.5

—

(3036489) Thrombin time

343

2297

1.52

11.80

2.0

20.76

21.10

0.37

313

2028

(4024509) Urine culture

426

3011

1.44

11.19

2.1

2.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

125

647

1.95

11.09

3.3

3.8

—

(3028707) Methadone [Presence] in Urine by Screen method

135

723

1.89

10.83

3.5

2.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6006

58088

1.32

10.81

6.5

6.0

2.61

2.70

mmol/l

10.85

5640

54108

(3006184) Hemoglobin [Mass/volume] in Capillary blood

244

1549

1.60

10.67

2.3

127.18

128.42

g/l

0.30

187

1197

(3025941) Bacteria identified in Stool by Culture

442

3174

1.42

10.65

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

687

5312

1.33

10.42

2.6

2.5

0.45

0.48

e6/l

0.09

656

5098

(3022145) Colonoscopy Study observation

900

7221

1.28

10.38

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

972

7889

1.27

10.20

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

699

5437

1.32

10.16

2.5

2.4

7.30

7.60

ug/l

0.10

615

4784

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

379

2677

1.44

10.01

1.7

2.0

39.79

39.54

u/l

0.09

339

2371

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.72

9.85

2.1

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

250

1634

1.55

9.67

1.7

1.6

—

(3025159) Blasts/Leukocytes in Blood

705

5529

1.31

9.65

5.1

4.7

0.85

0.35

0.41

174

1450

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5781

55773

1.26

9.63

23.1

16.7

79.81

79.20

ml/min/173m2

1.47

5426

51901

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

262

1733

1.53

9.60

2.5

2.4

196.68

197.88

0.08

248

1655

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

451

3316

1.39

9.49

2.5

2.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

254

1674

1.54

9.47

1.7

1.6

—

(3017181) Myelocytes/Leukocytes in Blood

727

5743

1.30

9.42

4.7

4.5

1.06

0.95

0.35

215

1781

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

244

1599

1.55

9.34

1.3

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

228

1474

1.57

9.27

1.2

1.3

1.16

4.12

u/ml

—

100

(1001926) Buprenorphine [Presence] in Urine by Screen method

206

1301

1.60

9.25

3.0

2.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5909

57215

1.27

9.15

5.5

5.3

4.54

4.63

mmol/l

8.44

5580

53491

(3002179) Metamyelocytes/Leukocytes in Blood

694

5471

1.30

9.13

4.4

4.3

0.68

0.71

0.16

208

1688

(3014765) Yersinia sp identified in Stool by Organism specific culture

244

1611

1.53

9.04

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

629

4903

1.31

8.99

2.7

2.3

13.10

13.27

nmol/l

0.19

561

4428

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

221

1431

1.56

8.94

1.6

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

240

1587

1.53

8.84

1.4

1.3

533.06

556.56

mg/l

0.22

233

1514

(3017704) Immunofixation for Urine

338

2.17

8.83

1.6

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5873

56871

1.26

8.77

5.4

5.2

1.44

1.47

mmol/l

3.86

5501

52829

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

216

1403

1.56

8.63

1.4

689.95

1217.65

e6/l

0.90

166

1113

(42529406) Shigella sp [Presence] in Stool by Culture

243

1621

1.52

8.60

1.3

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

161

976

1.67

8.55

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

275

1886

1.48

8.51

1.2

1.3

10.53

38.62

u/ml

—

101

(3024980) IgG subclass 4 [Mass/volume] in Serum

174

1078

1.63

8.49

1.4

1.6

0.78

0.77

g/l

0.02

129

836

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

212

1380

1.55

8.40

1.4

1.3

11.55

31.53

e6/l

1.49

157

1026

(3003181) Sodium [Moles/volume] in Urine

199

1279

1.57

8.34

1.4

60.38

61.37

mmol/l

0.14

161

1033

(3006653) Thiamine [Moles/volume] in Blood

315

2.17

8.24

1.3

1.2

136.85

134.97

nmol/l

0.15

315

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

388

2.05

8.23

1.2

1.1

6.61

11.31

nmol/l

0.35

(40760892) CBC W Ordered Manual Differential panel - Blood

1549

13476

1.19

8.19

5.6

4.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

199

2.47

8.03

1.3

1.2

41.00

39.21

g/l

0.44

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

280

1951

1.45

8.01

1.5

0.54

4.37

iu/ml

0.62

377

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1732

15241

1.18

8.01

4.8

4.5

22.17

21.97

0.18

773

7488

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

258

1770

1.48

7.99

1.6

1.5

14.27

14.49

iu/ml

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

120

2.93

7.94

1.4

1.2

111.27

85.36

mg/l

0.08

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

449

5865

0.75

7.92

1.9

2.0

3.48

3.49

ratio

0.05

339

4550

(3044242) Glucose [Moles/volume] in Arterial blood

361

2.06

7.87

2.3

2.0

7.29

8.10

mmol/l

1.43

361

(3026389) Candida sp identified in Specimen by Organism specific culture

144

868

1.67

7.85

1.5

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

289

2.19

7.84

1.9

2.0

88.78

127.99

umol/l

0.83

154

(3016879) Cocaine [Presence] in Urine

229

1540

1.50

7.83

2.8

2.1

—

(1761868) Lipid panel - Serum or Plasma

1989

22178

0.85

7.82

3.3

3.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

270

1878

1.46

7.80

2.2

2.1

94.99

92.35

1.21

260

1813

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

265

1839

1.46

7.75

1.9

1.8

—

32.21

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

245

1675

1.48

7.74

1.6

2.0

11.30

11.78

mg/l

0.45

232

1560

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

255

1760

1.47

7.68

1.3

7.49

4.68

u/ml

0.19

165

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

255

1764

1.46

7.59

1.3

8.02

7.61

u/ml

0.05

271

(3021440) Promyelocytes/Leukocytes in Blood

683

5499

1.27

7.59

4.8

4.5

0.10

0.12

172

1539

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

221

1488

1.50

7.53

1.1

11.81

9.20

eliau/ml

0.13

169

(3049717) Cytology report of Urine Cyto stain

327

2376

1.40

7.43

2.6

2.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

209

1395

1.51

7.43

1.2

37.70

43.37

u/ml

0.26

149

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

378

2.00

7.33

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2113

19011

1.16

7.28

5.7

5.5

2.24

3.04

ug/l

2.38

1920

17255

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

188

1240

1.53

7.08

1.6

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

208

1404

1.50

7.03

1.3

1.2

3.68

3.81

mmol/l

1.05

193

1326

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

185

1220

1.53

6.98

1.6

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

538

4251

1.29

6.96

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

337

2494

1.37

6.88

2.2

2.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

108

629

1.73

6.74

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

247

1741

1.43

6.70

5.4

4.1

3.91

3.89

mmol/l

0.30

247

1726

(3011985) Renin [Units/volume] in Plasma

147

930

1.59

6.67

1.5

1.4

62.03

63.87

mu/l

0.04

125

831

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

114

681

1.69

6.50

1.3

1.2

60.49

62.05

u/l

0.11

102

601

(3000764) Benzodiazepines [Presence] in Urine

236

1665

1.43

6.39

2.8

2.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

249

1775

1.42

6.37

1.3

—

(3045424) Erythrocytes [Presence] in Urine

410

3163

1.32

6.36

2.2

1.72

0.01

estimate

0.52

150

976

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

528

4211

1.28

6.35

4.2

3.7

5.22

5.15

kpa

1.25

502

4027

(3021387) Prolactin [Units/volume] in Serum or Plasma

233

1644

1.43

6.31

1.7

302.05

296.51

mu/l

0.11

213

1517

(3027944) Amphetamines [Presence] in Urine

233

1645

1.43

6.29

2.8

2.0

—

(3028300) Cannabinoids [Presence] in Urine

237

1679

1.43

6.28

2.9

2.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

217

2.22

6.27

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

561

4520

1.26

6.21

2.1

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

513

4089

1.28

6.21

2.0

1.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

111

668

1.67

6.18

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

202

1394

1.46

6.16

2.1

1.9

217.63

204.00

pmol/l

0.64

194

1319

(1002224) Polysomnography panel

362

2760

1.33

6.11

1.1

—

(3027008) Opiates [Presence] in Urine

235

1672

1.42

6.09

2.8

1.9

—

(3007566) Smooth muscle Ab [Titer] in Serum

251

1811

1.40

6.01

1.1

1.2

63.04

147.04

titre

1.69

162

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

453

3571

1.29

5.99

4.0

3.5

1.89

1.87

mmol/l

0.05

337

2652

(3024263) Appearance of Synovial fluid

343

1.93

5.98

2.3

1.6

—

(3009343) pH of Capillary blood

511

4090

1.27

5.98

4.2

3.7

7.41

7.42

1.55

433

3404

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

177

2.32

5.97

2.0

8.29

9.13

mg/l

0.40

150

(4198724) Urine methamphetamine measurement

190

2.27

5.94

3.3

2.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

281

2071

1.37

5.93

2.2

1.9

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

623

5111

1.24

5.89

2.8

2.7

64.70

65.50

ml/min/173m2

0.21

282

2170

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.29

5.85

1.2

1.3

—

(3035933) Granulocytes/Leukocytes in Blood

190

1310

1.46

5.85

3.1

3.3

57.82

58.25

0.19

190

1310

(3023511) Choriogonadotropin [Units/volume] in Urine

104

625

1.67

5.84

1.5

1.3

—

(3022621) pH of Urine by Test strip

601

4918

1.24

5.82

3.2

2.8

6.11

6.06

0.68

431

3375

(3020717) Zinc [Moles/volume] in Serum or Plasma

335

1.92

5.70

1.5

1.4

20.14

23.05

umol/l

0.38

307

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

329

4283

0.76

5.69

1.6

1.7

3.39

3.48

mmol/l

0.73

226

2977

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

125

793

1.59

5.67

1.2

1.3

—

nmol/l

—

(3018333) Ribosomal P Ab [Presence] in Serum

467

1.77

5.60

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

170

1158

1.48

5.58

1.3

1.2

129.09

352.24

titre

2.05

(3024891) Influenza virus A+B Ag [Presence] in Specimen

206

1457

1.43

5.56

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

374

4767

0.77

5.52

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.99

5.52

1.2

6.87

6.03

mmol/l

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

141

926

1.53

5.51

1.2

1.3

0.57

3.77

nmol/l

0.80

131

893

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

477

1.75

5.50

1.2

—

(3044927) Protein electrophoresis panel - Urine

106

652

1.64

5.47

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

449

1.77

5.44

1.4

1.3

2.73

1.18

u/ml

0.48

263

(3034274) Bile acid [Moles/volume] in Serum --fasting

494

1.73

5.43

1.6

1.9

8.12

8.44

umol/l

0.05

351

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

218

2.12

5.40

1.8

2.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

195

1376

1.43

5.34

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

132

861

1.54

5.34

1.2

1.3

294.97

336.27

pmol/l

0.54

117

732

(3023410) Appearance of Cerebral spinal fluid

603

1.65

5.32

1.4

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

207

2.13

5.27

4.7

3.3

5.04

4.88

kpa

0.50

207

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

483

3901

1.26

5.27

1.2

103.48

135.63

u/ml

1.46

194

1450

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

208

2.12

5.21

4.7

3.3

10.01

10.26

kpa

0.24

208

(40759836) Histone Ab [Presence] in Serum by Immunoblot

509

1.70

5.16

1.2

—

(40761536) Microorganisms panel - Urine sediment

580

4794

1.23

5.13

5.0

4.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

171

2.23

5.08

1.1

95.29

88.71

0.98

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

489

1.71

5.07

1.2

—

(40768804) Tissue Pathology biopsy report

2641

24560

1.12

5.06

2.3

2.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

486

3947

1.25

5.06

1.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

204

2.11

5.05

1.1

1.3

0.32

0.30

g/l

0.67

164

(40768443) Skin Pathology biopsy report

363

2849

1.29

5.01

1.3

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

185

2.17

5.01

1.3

156.94

125.42

nmol/l

0.43

134

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

142

955

1.50

5.01

1.2

1.3

0.39

0.27

nmol/l

0.29

(3010838) Calcium [Moles/time] in 24 hour Urine

163

1128

1.46

4.98

1.7

1.9

4.80

4.87

mmol/24h

0.10

149

998

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

417

1.76

4.98

1.4

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

500

1.69

4.95

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

500

1.69

4.95

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

111

2.53

4.94

1.2

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

601

1.62

4.91

3.9

3.3

14.35

13.06

index

0.33

339

(3001186) Copper [Moles/volume] in Serum or Plasma

161

2.24

4.90

1.3

1.2

16.33

16.65

umol/l

0.13

139

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

427

1.74

4.88

1.4

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

148

1010

1.48

4.87

1.7

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

105

666

1.59

4.83

1.5

1.4

6.20

6.82

g/l

1.16

483

(3004716) Salmonella sp identified in Stool by Organism specific culture

333

2599

1.30

4.81

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

249

1.97

4.81

2.4

2.3

51.37

52.81

umol/l

0.09

214

(40762814) Titanium [Mass/volume] in Blood

2.64

4.81

2.8

2.4

2.72

3.93

ug/l

1.21

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

423

1.73

4.76

2.1

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

295

2269

1.31

4.76

3.1

3.0

24.69

24.80

mmol/l

0.20

290

2237

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

522

1.66

4.73

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

507

1.67

4.72

1.4

1.5

26.83

21.41

u/ml

0.24

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

373

1.78

4.69

1.1

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

104

665

1.57

4.64

1.5

1.4

2.59

2.91

g/l

1.16

485

(3024139) IgG subclass 3 [Mass/volume] in Serum

104

665

1.57

4.64

1.5

1.4

0.35

0.40

g/l

0.75

482

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

510

1.66

4.63

1.6

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

172

2.16

4.61

1.2

1.3

99.50

88.51

1.06

(1616796) Gas panel - Central venous blood

195

1416

1.39

4.59

4.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

473

1.68

4.59

1.3

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

515

4258

1.23

4.56

1.2

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

206

2.05

4.56

1.3

1.4

216.19

232.89

nmol/24h

0.03

206

(3012501) Base excess in Blood by calculation

180

1292

1.40

4.54

4.1

4.4

2.55

2.59

mmol/l

0.06

124

896

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

377

1.76

4.54

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

228

1703

1.35

4.51

2.1

2.0

4.00

7.14

iu/l

0.45

705

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

610

5136

1.21

4.50

3.8

4.1

1.23

mmol/l

0.16

526

4455

(3009466) Valproate [Moles/volume] in Serum or Plasma

122

816

1.50

4.46

5.4

5.5

345.08

358.31

umol/l

0.45

107

720

(37208534) Antinuclear antibody arbitrary concentration in serum

188

2.08

4.44

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

102

657

1.56

4.43

2.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

632

7427

0.84

4.40

5.3

5.1

32.12

32.58

0.50

459

4881

(4062490) Immunoglobulin typing, IgG

102

658

1.56

4.40

1.5

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

165

1175

1.41

4.37

1.6

1.3

42.06

34.86

u/l

0.21

150

1021

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

345

1.78

4.35

2.1

2.5

41.91

40.04

0.27

191

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

591

1.58

4.29

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

120

809

1.49

4.24

1.3

0.18

0.21

nmol/l

0.58

646

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

212

1.99

4.24

1.7

1.5

14.37

15.47

pmol/l

0.60

178

(3008295) Osmolality of Serum or Plasma

110

729

1.52

4.22

1.3

1.4

277.95

277.01

mosm/kgh2o

0.16

551

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

199

2.02

4.21

1.2

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

289

2257

1.29

4.20

1.7

1.6

14.65

18.19

u/ml

0.54

513

(3017569) Oxygen content in Arterial blood

364

1.74

4.19

2.6

2.3

15.06

16.20

2.55

364

(3016650) Hepatitis A virus Ab [Presence] in Serum

147

1035

1.43

4.17

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

395

1.70

4.16

1.3

1.2

83.48

91.13

u/l

0.34

334

(3013005) Retinol [Moles/volume] in Serum or Plasma

257

1.87

4.10

1.6

2.09

1.99

umol/l

0.35

233

(3027923) C peptide [Moles/volume] in Serum or Plasma

347

1.74

4.00

1.6

1.4

1.24

1.28

nmol/l

0.12

252

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

363

1.71

3.96

1.2

24.02

26.33

u/l

0.15

325

(3000012) Reticulocyte production index

135

946

1.44

3.95

2.0

2.1

0.77

0.89

1.80

644

(3035320) C reactive protein [Mass/volume] in Body fluid

486

1.61

3.94

3.1

2.7

27.97

29.60

mg/l

0.16

354

(3042517) Benzodiazepines panel - Urine

3.26

3.90

2.4

2.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5566

54367

1.14

3.88

4.5

4.4

1.37

1.30

mmol/l

7.97

5168

49978

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

504

1.59

3.87

1.2

172.14

191.63

titre

0.08

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

382

1.68

3.83

1.4

1.2

23.34

26.44

u/l

0.25

316

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

179

1325

1.36

3.81

1.3

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

130

1819

0.71

3.71

1.1

0.64

0.63

ratio

0.06

254

(3024869) Neuronal Ab [Presence] in Serum

109

2.30

3.67

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

357

2912

1.24

3.65

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

366

1.67

3.60

1.2

88.39

84.79

u/l

0.17

328

(3002619) Bacteria identified in Specimen by Culture

143

2.10

3.58

1.3

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

603

1.52

3.56

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

189

1428

1.33

3.55

1.3

1.4

11.60

10.92

u/l

0.28

151

1169

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.57

3.54

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1272

0.66

3.51

3.9

3.6

27.93

27.17

mg/l

0.07

888

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

197

1501

1.32

3.49

1.7

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

180

1.95

3.42

1.1

—

(3004451) EKG impression Narrative

387

1.63

3.42

1.2

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

593

1.51

3.41

2.4

3.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

180

1362

1.33

3.36

2.1

3570.49

5143.63

u/l

0.40

558

(3027273) Bicarbonate [Moles/volume] in Venous blood

352

2895

1.23

3.36

3.0

3.5

25.38

25.21

mmol/l

0.36

334

2808

(3020961) Endomysium IgA Ab [Titer] in Serum

335

2741

1.23

3.36

1.1

172.00

154.95

titre

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

108

2.23

3.31

1.3

109.40

81.39

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

108

2.23

3.31

1.2

109.20

79.81

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

315

1.69

3.27

1.4

1.7

9.96

5.23

nmol/l

0.25

254

(3012920) Ethanol [Mass/volume] in Serum or Plasma

8.58

3.26

1.2

2.0

1.82

2.11

g/l

—

(3003694) ABO and Rh group [Type] in Blood

1789

16609

1.11

3.22

1.5

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.67

3.22

1.9

1.6

51.00

44.22

umol/l

0.41

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

302

1.69

3.20

2.0

2.1

146.89

189.95

ug/min

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

151

1125

1.35

3.15

1.7

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

211

1649

1.29

3.14

1.4

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

174

1326

1.32

3.12

4.2

5.6

623.93

1684.28

iu/ml

0.41

185

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

237

1.78

3.12

1.8

1.3

2.68

4.35

umol/l

2.81

207

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

142

1050

1.36

3.12

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

382

1.60

3.10

1.8

2.5

214.44

229.49

e6/l

0.32

328

(3016038) Potassium [Moles/volume] in Urine

461

1.55

3.09

1.3

1.2

33.90

35.29

mmol/l

0.20

399

(3006922) Hepatitis E virus Ab [Presence] in Serum

486

1.53

3.07

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

134

991

1.36

2.96

1.2

1.1

—

0.91

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.64

2.96

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

302

1.66

2.94

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

163

1.91

2.89

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

296

1.66

2.89

5.5

6.1

120.89

619.19

u/ml

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

193

1.82

2.83

1.3

2.2

173.91

182.48

0.18

183

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

116

846

1.38

2.81

1.1

118.70

116.50

0.34

105

764

(3002256) Pathology report gross observation

917

8267

1.13

2.81

1.4

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

315

1.62

2.77

1.2

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

315

1.62

2.77

1.2

1.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.92

2.77

1.1

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

174

1.84

2.71

1.8

1.6

0.38

0.37

ug/l

0.07

120

(3045788) Cell count panel - Pleural fluid

649

1.42

2.71

1.4

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

452

1.51

2.71

1.2

1.1

35.94

43.15

mg/l

1.08

377

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

124

921

1.35

2.70

1.3

1.2

5.07

3.61

u/ml

0.40

309

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.50

2.69

1.2

1.3

37.70

122.00

ug/l

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.50

2.69

1.0

1.1

0.00

0.50

u/ml

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

318

1.61

2.68

3.3

4.0

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

437

1.52

2.68

1.2

1.1

266.90

282.29

mg/l

0.33

381

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

113

828

1.37

2.68

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.75

2.67

1.0

0.03

0.17

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

112

2.06

2.66

1.1

1.0

28.59

37.47

iu/ml

0.39

112

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.79

2.64

1.2

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

646

1.41

2.61

1.1

—

4.59

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

120

2.00

2.60

1.1

0.73

0.67

umol/24h

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

232

1883

1.24

2.58

3.1

1.61

1.58

mg/l

0.22

206

1717

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

417

1.52

2.58

1.1

—

0.62

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

393

1.53

2.57

1.7

1.6

3.61

6.76

u/l

1.65

322

(3033705) Calcium.ionized [Moles/volume] in Venous blood

679

0.62

2.57

2.1

2.3

1.18

1.20

mmol/l

1.38

669

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

163

1.84

2.56

1.1

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.86

2.54

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

2.50

2.52

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

308

1.60

2.51

1.4

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

293

2444

1.21

2.51

2.1

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

428

1.50

2.50

1.3

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

289

2409

1.21

2.50

2.6

3.6

419.36

2847.36

u/ml

1.33

246

2085

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

372

1.54

2.49

1.8

2.4

577.75

514.20

e6/l

0.35

301

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

109

2.02

2.45

1.4

1.6

—

(3041354) Potassium [Moles/volume] in Venous blood

695

0.63

2.45

2.1

2.3

4.10

4.07

mmol/l

0.12

685

(3035285) Chloride [Moles/volume] in Venous blood

695

0.63

2.45

2.1

2.3

106.00

105.44

mmol/l

0.43

685

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

186

1484

1.26

2.43

1.2

1.1

3.24

3.82

0.52

175

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

327

1.56

2.42

1.3

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.29

2.40

2.3

1.8

—

(3020491) Glucose [Moles/volume] in Blood

424

1.49

2.40

2.0

2.1

7.30

6.73

mmol/l

0.95

289

(3013512) EKG study

2285

21698

1.08

2.36

3.8

0.63

0.75

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

410

1.49

2.35

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

207

1685

1.24

2.28

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

271

1.59

2.22

1.3

1.2

158.10

165.83

mmol/24h

0.22

271

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

180

1.73

2.18

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

180

1.73

2.18

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

180

1.73

2.18

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

180

1.73

2.18

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

644

1.37

2.17

1.1

98.02

96.05

0.29

605

(3037121) Protein [Mass/volume] in Urine

259

2170

1.20

2.16

3.0

3.2

249.36

464.02

mg/l

2.82

104

948

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

394

1.48

2.15

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.69

2.15

1.0

1.1

—

(3011412) CD3 cells [#/volume] in Blood

570

1.39

2.13

1.9

2.3

1284.50

1150.96

e6/l

0.44

506

(3040151) Glucose [Moles/volume] in Capillary blood

715

1.35

2.13

3.5

14.6

8.62

7.37

mmol/l

0.44

607

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.14

2.08

1.7

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.14

2.08

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

112

1450

0.77

2.06

4.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1040

0.73

2.05

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

103

1.94

2.04

1.4

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

4.00

2.04

1.5

4.03

4.49

mmol/l

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

143

1133

1.27

2.03

1.8

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

609

1.37

2.03

1.6

1.7

—

(3028433) Virus identified in Specimen by Culture

184

1.69

2.03

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

132

1.82

2.03

1.0

1.3

1.64

1.71

mmol/l

0.11

(3043410) Blood group antigens tested for on Red Blood Cells

155

1.74

1.99

1.7

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

451

1.42

1.99

1.6

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

656

1.35

1.96

1.6

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.94

1.6

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

129

1626

0.79

1.94

1.4

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

116

903

1.29

1.92

1.3

1.2

6.24

4.59

u/ml

0.45

393

(3003434) Protein [Mass/volume] in Pleural fluid

117

912

1.29

1.91

1.3

1.5

31.72

32.22

g/l

0.17

110

825

(3001019) Free T4 and TSH panel - Serum or Plasma

220

2618

0.83

1.90

1.9

1.7

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.05

1.90

1.3

1.6

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

307

1.50

1.89

1.4

1.3

52.86

66.14

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

635

1.34

1.88

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

340

1.47

1.88

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

357

1.46

1.87

1.1

—

(3042631) Mycobacterium sp identified in Specimen

111

864

1.29

1.85

2.3

2.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

106

821

1.30

1.83

1.8

1.6

—

(4195642) Thrombophilia screening test

109

848

1.29

1.83

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

137

1.75

1.82

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

302

1.49

1.81

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

183

1.64

1.81

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

418

1.42

1.81

1.1

8.23

9.02

iu/ml

0.13

115

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.06

1.80

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.92

1.79

1.3

1.2

70.61

65.55

ug/l

0.40

(3029396) Erythrocyte agglutination [Presence] in Blood

2.00

1.79

3.2

3.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

521

1.37

1.78

4.2

5.6

124.40

64.99

u/ml

0.43

170

(3023323) Follitropin [Units/volume] in Serum or Plasma

280

2410

1.17

1.77

1.5

1.4

29.71

30.87

iu/l

0.25

246

2077

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

565

1.35

1.76

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1.46

1.76

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

261

2236

1.17

1.75

4.6

3.8

24.83

24.93

mmol/l

0.22

240

2043

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

3.34

1.74

1.2

1.4

1.43

1.38

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

653

1.32

1.73

1.9

1.8

413.33

1240.00

titre

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

464

1.38

1.73

1.1

1.0

856.84

728.64

ng/l

1.06

321

(3042010) Triglyceride [Moles/volume] in Pleural fluid

110

1.82

1.72

1.0

1.3

0.72

1.80

mmol/l

0.78

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

155

1.68

1.72

1.2

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

389

1.42

1.72

1.3

1.2

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

1.70

0.0

4.3

—

0.00

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

332

1.45

1.69

1.4

1.2

0.56

0.55

ratio

0.12

198

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

467

1.37

1.68

1.1

1.0

34.09

42.17

ng/l

1.30

329

(44806420) Estimation of glomerular filtration rate

646

0.69

1.67

3.4

2.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

101

789

1.28

1.67

1.4

1.5

1845.69

3545.12

e6/l

0.79

548

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

263

2266

1.17

1.66

2.0

1.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.50

1.66

1.5

2.5

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.44

1.64

1.6

1.8

11.90

20.71

pmol/l

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

462

1.37

1.61

1.1

1.0

286.64

320.94

ng/l

0.46

330

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

143

1.68

1.60

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

117

937

1.25

1.59

1.3

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

515

1.34

1.59

1.8

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

550

1.33

1.58

1.2

—

79.57

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

164

1363

1.21

1.58

3.5

3.3

0.83

0.82

nmol/l

0.09

138

1105

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.03

1.54

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

306

1.44

1.53

3.1

2.9

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

130

1060

1.23

1.52

1.9

2.7

243.38

1948.41

u/ml

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.59

1.51

1.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

138

1134

1.22

1.50

1.2

287.48

280.69

u/ml

0.06

705

(4015189) Microbial culture of sputum

154

1.63

1.49

2.1

2.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.90

1.49

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.07

1.49

1.1

0.03

u/ml

0.08

(3003888) Timothy IgE Ab [Units/volume] in Serum

117

949

1.24

1.45

1.1

2.98

4.15

u/ml

0.52

480

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

179

1.57

1.45

2.9

3.1

5.64

8.44

mg/l

2.47

145

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

156

1.60

1.43

2.4

2.6

358.96

118.25

au/ml

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

425

0.66

1.42

1.4

1.6

2.74

4.00

ug/l

0.73

348

(3004616) Nuclear Ab [Presence] in Serum

781

1.26

1.42

1.3

—

(4035726) Immunohistochemistry procedure

510

5593

0.90

1.40

1.3

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

912

8526

1.08

1.40

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

126

1.67

1.39

1.0

1.1

0.52

1.40

u/ml

0.47

(3047189) Immunofixation for 24 hour Urine

313

1.41

1.38

1.9

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.08

1.38

1.3

1.1

5.91

6.07

mmol/l

0.43

(3000060) B lymphocytes [#/volume] in Blood

142

1.62

1.38

1.3

2.0

0.20

0.16

e9/l

0.22

(3004775) Volume in Urine collected for unspecified duration

468

0.68

1.36

2.7

2.2

815.91

629.29

1.26

310

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.61

1.36

1.0

0.03

0.11

u/ml

—

(3020876) Protein [Mass/time] in 24 hour Urine

102

822

1.24

1.36

2.2

2.3

1.38

1.29

g/24h

0.13

468

(4268621) Lupus anticoagulant assay

644

1.28

1.35

2.4

2.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

134

1113

1.21

1.34

1.2

1.1

1.07

1.87

u/ml

1.31

592

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

151

1.59

1.34

1.1

—

(4281824) Cell count and differential, peritoneal fluid

696

0.75

1.32

1.1

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

108

879

1.23

1.32

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

476

0.69

1.32

1.0

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

532

1.30

1.32

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

532

1.30

1.32

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

532

1.30

1.32

1.6

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

106

862

1.23

1.31

2.0

1.8

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

1.31

0.0

3.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

143

1199

1.20

1.31

2.3

1.9

0.89

0.87

nmol/l

0.10

118

1017

(3037692) Legionella sp identified in Specimen by Organism specific culture

225

1.47

1.30

1.6

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.09

1.30

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.09

1.30

1.1

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.35

1.29

1.1

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.35

1.29

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

2.78

1.28

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

161

1.55

1.28

1.2

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.79

1.26

1.9

2.5

32.60

31.59

mg/l

—

(44813793) Dust mix specific IgE antibody measurement

396

1.34

1.26

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.29

1.26

1.3

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

260

1.43

1.26

2.1

4.3

54.16

61.71

mg/l

0.46

182

(3000034) Microalbumin [Mass/volume] in Urine

563

1.28

1.25

3.4

3.1

47.72

44.88

mg/l

0.04

418

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.82

1.25

1.2

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.40

1.24

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

287

1.40

1.23

2.0

1.7

2.63

3.22

u/field

0.20

201

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

495

1.30

1.21

1.1

298.88

290.47

mg/l

0.36

453

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.16

1.21

1.5

343.75

344.08

umol/24h

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

566

1.28

1.21

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

177

1524

1.17

1.21

1.3

199.35

219.75

miu/ml

0.26

671

(3022313) Gas panel - Capillary blood

320

2869

1.12

1.20

4.6

3.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

129

1082

1.20

1.3

1.4

138.25

153.00

au/ml

0.60

313

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

542

1.28

1.17

1.6

1.7

342.04

332.71

mu/l

0.06

429

(3012565) Volume of 24 hour Urine

307

1.37

1.17

1.8

2.4

1944.16

1893.70

0.14

274

(40768793) Breast Pathology biopsy report

129

1526

0.84

1.16

1.3

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.05

1.15

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

320

0.66

1.14

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

275

1.38

1.13

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

103

1.65

1.12

2.5

2.1

14.16

17.79

umol/l

0.93

103

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.33

1.12

11.7

9.8

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.90

1.12

1.0

1.1

0.16

1.01

u/ml

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

167

1.50

1.12

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

690

1.23

1.11

1.1

—

(4034850) Laboratory test

212

1865

1.14

1.10

13.6

10.4

—

(3042733) HLA Ab [Presence] in Serum

195

0.56

1.10

4.5

4.9

—

(3006462) Nitrate [Presence] in Urine

268

1.38

1.10

3.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.38

1.09

1.6

1.4

426.80

509.05

nmol/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.95

1.08

1.1

1.2

—

(4211845) Urine protein measurement

295

1.36

1.07

3.5

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.12

1.05

1.0

1.4

1.20

0.76

umol/l

—

(3036782) Glucose [Moles/volume] in Pleural fluid

642

1.23

1.04

1.2

1.4

6.38

6.30

mmol/l

0.12

604

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

742

1.22

1.03

1.1

2.14

3.42

eliau/ml

0.71

324

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.83

1.02

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

519

1.25

1.00

1.1

1.2

110.57

106.08

pmol/l

0.34

519

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.77

1.00

1.1

1.0

10.18

8.04

u/ml

0.14

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

222

1.40

1.00

1.7

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

222

1.40

1.00

1.7

1.9

—

(3019225) pH of Specimen

566

6069

0.93

1.00

4.6

4.4

7.37

7.36

0.52

429

4355

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

109

920

1.19

0.99

1.1

17.44

12548.45

iu/ml

0.54

187

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

140

1207

1.16

0.99

1.3

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

223

1.39

0.98

1.7

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

310

1.32

0.96

2.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

233

1.38

0.95

2.6

2.8

0.61

mmol/l

0.08

233

(3016750) Collection duration of Urine

341

0.70

0.95

2.8

2.1

514.00

494.24

min

0.46

255

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

109

925

1.18

0.94

1.1

17.15

18.39

au/ml

0.06

213

(4133840) Spirometry

133

1.51

0.94

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

539

5030

1.08

0.93

1.5

1.4

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

145

0.55

0.92

5.4

3.0

186.75

2035.49

u/l

—

134

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.73

0.92

1.1

1.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

472

1.25

0.92

1.2

1.3

15.15

13.00

u/l

0.40

433

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

134

1.49

0.91

1.4

1.2

394.07

299.45

pmol/l

0.27

(3008037) Lactate [Moles/volume] in Venous blood

137

1575

0.87

0.91

2.6

3.1

1.52

1.61

mmol/l

0.60

132

1527

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

313

1.31

0.91

1.5

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

313

1.31

0.91

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

313

1.31

0.91

1.5

1.8

—

(3017354) Segmented neutrophils/Leukocytes in Blood

691

1.20

0.90

2.5

3.6

59.96

57.25

0.60

594

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

420

1.26

0.89

1.9

110.05

111.71

ng/l

0.03

420

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1182

11325

1.05

0.89

3.4

3.2

0.75

0.77

ug/l

0.13

804

7412

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.91

0.88

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

785

1.19

0.87

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.72

0.86

1.1

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

361

1.28

0.85

5.6

7.0

6.61

133.98

ug/l

1.32

229

(3045142) Bone marrow Pathology biopsy report

752

1.19

0.84

1.2

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.74

0.82

6.0

5.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

310

1.29

0.82

1.1

1.0

0.39

2.35

u/ml

0.96

(3051339) Copper [Moles/volume] in Blood

1.88

0.81

1.5

1.2

17.58

16.57

umol/l

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

699

1.19

0.81

1.4

1.5

28040.33

64724.04

e6/l

1.55

387

(3008401) Mugwort IgE Ab [Units/volume] in Serum

107

921

1.16

0.81

1.1

0.87

1.03

u/ml

0.17

386

(3014891) Appearance of Pleural fluid

1.57

0.81

1.4

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

311

1.29

0.80

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

793

1.18

0.80

1.1

1.96

2.88

0.47

118

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

224

1.34

0.79

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

365

1.26

0.79

1.1

33.36

19.64

u/ml

0.78

152

(3022475) Manganese [Moles/volume] in Blood

1.82

0.79

1.5

1.4

0.17

umol/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

597

0.80

0.79

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

656

1.19

0.78

1.4

1.3

1.46

1.54

nmol/l

0.28

587

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.59

0.78

1.2

48.47

60.27

ng/l

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

313

1.28

0.77

1.5

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

806

1.17

0.76

1.2

—

(3024932) HLA-DR beta [Type]

174

0.63

0.76

1.1

—

(40758358) Immune stain study

0.00

0.76

0.0

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

1.67

0.74

1.1

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

141

1.42

0.74

2.5

2.4

431.90

256.89

ug/l

0.15

141

(3023430) Cat dander IgE Ab [Units/volume] in Serum

726

1.17

0.73

1.0

1.1

3.50

3.69

u/ml

0.03

312

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.64

0.73

1.1

1.65

1.71

umol/24h

—

(40758292) HTLV I+II Ab panel - Serum

108

1.48

0.73

1.4

—

(3033099) Centromere Ab [Titer] in Serum

142

1.41

0.72

1.4

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

626

1.18

0.72

2.8

4.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

765

1.17

0.71

2.3

2.1

23.69

23.78

mg/l

0.01

268

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

617

1.19

0.71

1.3

1.4

537.94

342.79

u/l

0.46

589

(40768800) Prostate Pathology biopsy report

106

1213

0.87

0.71

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

100

869

1.15

0.70

1.1

1.53

1.41

u/ml

0.06

421

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

247

1.30

0.70

1.0

1.1

90.29

94.80

0.35

190

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.55

0.69

1.3

1.1

88.89

85.52

titre

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

283

1.27

0.69

1.8

1.4

1568600.00

1376209.93

iu/ml

—

(40768806) Pleura Pathology biopsy report

694

1.17

0.68

1.4

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

620

1.18

0.68

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

178

1.35

0.68

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

178

1.35

0.68

1.8

1.6

8.40

9.02

ug/l

0.30

178

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.56

0.68

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

213

1.32

0.68

1.5

1.8

0.32

0.03

estimate

0.94

213

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

102

1.47

0.67

1.2

1.3

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

249

1.29

0.67

1.2

1.3

8.66

10.66

mm/h

0.55

249

(3004809) Band form neutrophils/Leukocytes in Blood

122

1080

1.13

0.67

2.7

3.7

1.56

1.60

0.05

107

964

(3005033) Fetal Nuchal fold Thickness US

613

1.18

0.66

1.5

1.27

1.26

0.14

432

(3024471) HLA-A [Type]

179

0.67

0.66

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.59

0.65

6.4

4.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

103

1.46

0.64

2.2

2.1

—

(40757373) Influenza virus identified in Isolate

120

1.42

0.64

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

129

1.40

0.63

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

515

1.19

0.63

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

104

1.44

0.62

2.2

2.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.57

0.60

1.3

1.9

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

209

0.72

0.59

1.2

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

336

1.22

0.58

1.3

2.6

205.22

202.33

u/l

0.09

331

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

140

1.36

0.58

1.3

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

391

1.20

0.58

1.3

168.90

188.34

pmol/l

0.27

391

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.46

0.58

1.1

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

149

1.34

0.57

5.4

7.5

4.91

5.40

kpa

1.04

149

(3010375) cycloSPORINE [Mass/volume] in Blood

275

0.76

0.56

30.4

26.2

110.81

111.85

ug/l

0.03

218

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.46

0.56

1.4

1.1

—

11.52

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

643

1.15

0.56

1.6

1.5

—

(21494434) Karyotype in Bone marrow

578

1.16

0.55

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

229

0.74

0.55

1.2

1.6

—

(3007916) DNA double strand Ab [Titer] in Serum

1.54

0.55

1.1

1.2

—

64.38

—

(3002523) Influenza virus A Ag [Presence] in Specimen

104

926

1.13

0.55

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

295

1.22

0.52

1.1

1.0

0.62

1.50

u/ml

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

196

1.28

0.52

1.5

1.3

70.08

53.76

1.72

166

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

341

1.20

0.52

1.1

1.05

1.06

ratio

0.25

272

(3017509) Phencyclidine [Presence] in Urine

1.50

0.51

1.0

1.3

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.41

0.51

1.2

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

144

1.32

0.50

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

715

6889

1.04

0.48

3.2

4.3

32.19

23.42

ug/l

0.22

595

5625

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

326

1.20

0.48

1.1

1.20

1.15

u/l

0.21

154

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.52

0.48

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

103

927

1.11

0.48

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

777

1.12

0.46

1.1

6.47

2.77

u/ml

0.89

373

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

825

1.12

0.46

1.6

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

182

1.26

0.46

1.3

1.2

545.24

310.03

ug/l

0.17

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

291

1.20

0.46

1.4

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

291

1.20

0.46

1.4

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

120

1.33

0.46

5.6

7.1

9.93

10.49

0.40

120

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.43

0.46

1.1

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

228

1.23

0.45

1.1

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.40

0.44

1.1

1.2

—

(3025130) Human papilloma virus identified in Specimen

781

1.12

0.43

1.6

1.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

293

1.20

0.43

1.1

1495.54

1518.79

miu/ml

0.05

293

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

266

1.20

0.43

1.1

163.31

335.44

ng/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

679

1.12

0.42

1.4

1.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

123

1.30

0.40

1.8

1.9

—

(3001729) Color of Synovial fluid

1.33

0.40

2.0

1.5

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.8

—

1.90

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

204

0.78

0.39

1.3

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

808

1.10

0.38

1.6

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

339

3235

1.05

0.38

2.6

3.8

71.49

68.39

u/ml

0.03

323

3114

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.39

0.38

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.34

0.38

1.2

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

125

1.28

0.36

1.3

36.87

71.05

mu/l

1.20

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.39

0.36

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.36

0.36

1.3

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

267

0.82

0.36

1.7

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

192

1807

1.06

0.36

1.1

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.64

0.35

4.0

6.4

10.20

8.38

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.64

0.35

2.0

3.2

29.20

45.41

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

517

1.12

0.35

1.8

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

385

1.14

0.35

1.9

1.5

83.00

82.19

umol/l

0.06

385

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

208

1.20

0.35

2.9

2.8

31.91

28.39

umol/l

0.79

148

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.40

0.35

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

566

1.11

0.34

1.6

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

219

1.19

0.33

1.7

1.6

2560.00

3713.33

titre

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

231

0.82

0.32

1.4

1.5

47.43

65.27

1.08

190

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

209

0.81

0.32

1.4

1.9

1064.00

17136.12

e6/l

—

108

(3026692) Albumin [Mass/volume] in Peritoneal fluid

187

0.80

0.32

1.3

1.5

10.72

12.97

g/l

—

139

(3005011) Chlamydia sp Ab [Titer] in Serum

1.33

0.32

1.7

—

(3006270) Folate [Moles/volume] in Blood

512

1.11

0.31

1.2

353.82

355.55

nmol/l

0.02

438

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.30

0.31

20.4

12.0

7.55

5.57

mmol/l

0.44

(3032868) Hemoglobin electrophoresis panel in Blood

1.32

0.30

1.4

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

724

1.09

0.30

1.4

1.3

32.47

31.07

u/l

0.14

589

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.30

0.30

1.0

1.1

5.00

15.37

u/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

357

0.87

0.30

1.2

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

372

1.13

0.29

1.8

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

775

1.08

0.29

1.6

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

260

1.15

0.28

1.1

13.50

20.54

u/ml

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

814

1.08

0.28

1.6

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

867

0.92

0.28

2.2

2.6

5.40

540.19

u/ml

0.96

855

(3005988) Vibrio sp identified in Specimen by Organism specific culture

778

1.08

0.27

1.6

1.4

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.21

0.26

1.6

1.4

3.96

13.38

pmol/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.22

0.25

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.22

0.25

2.1

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

735

7192

1.02

0.25

9.6

7.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.18

0.24

2.3

1.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

142

1.20

0.24

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

773

1.07

0.24

1.6

1.4

—

(3000330) Specific gravity of Urine by Test strip

330

3193

1.04

0.24

3.2

3.5

1.02

ratio

0.35

290

2897

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

494

1.09

0.23

1.3

1.5

62.14

57.84

ug/l

0.36

494

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

1.8

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

2.5

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.4

—

39.47

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

135

1.19

0.21

1.0

1.1

—

16.00

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

934

1.06

0.21

1.3

1.5

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

258

1.12

0.21

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

137

1437

0.95

0.21

2.4

3.5

69.72

753.19

u/ml

2.74

126

1308

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

30.00

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

144

1375

1.05

0.20

1.5

1.6

1181.84

1029.91

mu/l

0.99

118

1126

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.13

0.18

3.3

2.5

0.17

0.62

u/field

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

166

1.14

0.18

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.15

0.17

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

721

0.94

0.16

1.2

6.80

7.42

mmol/l

1.16

633

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1.10

0.16

1.4

1.8

39.70

39.66

g/l

0.02

273

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

182

0.88

0.15

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

604

0.94

0.14

2.6

2.4

35.44

30.91

iu/ml

0.14

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

138

0.87

0.13

1.7

4.71

2.09

ug/l

—

(4146454) Self-monitoring of blood glucose

683

0.95

0.13

2.8

2.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

146

1418

1.03

0.11

2.4

2.3

87.18

105.57

ug/min

0.35

849

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

466

0.94

0.11

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

670

0.95

0.11

1.1

0.23

0.25

u/ml

0.06

220

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

201

1.09

0.11

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

240

0.92

0.11

1.8

2.1

320.55

4062.41

e6/l

0.59

164

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.16

0.11

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.16

0.11

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.16

0.11

1.0

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

740

1.04

0.11

1.5

1.10

1.16

ratio

0.26

458

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

741

1.04

0.10

1.5

1.14

1.20

ratio

0.25

462

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

741

1.04

0.10

1.5

0.91

0.95

ratio

0.44

459

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

388

1.06

0.10

1.8

1.5

—

(3013727) Leukocytes other/Leukocytes in Blood

197

0.91

0.09

3.3

3.6

45.83

54.37

1.36

190

(3019174) dRVVT (LA screen)

1.06

0.09

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

145

1.10

0.09

1.1

1.4

1.17

mmol/l

0.11

145

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

734

1.04

0.09

1.5

1.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

165

0.91

0.08

1.0

21.83

9.20

u/ml

—

109

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

134

0.90

0.08

1.3

—

(40768795) Lymph node Pathology biopsy report

633

0.96

0.08

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

277

0.94

0.08

3.9

3.2

1.71

1.27

0.51

277

(3001893) Eosinophils/Leukocytes in Pleural fluid

195

1.08

0.08

1.3

1.5

12.86

2.53

1.33

167

(40768441) Liver Pathology biopsy report

470

1.04

0.08

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.87

0.06

1.5

0.44

0.48

e9/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

194

1970

0.98

0.06

1.7

1.8

6.02

4.55

mg/l

0.62

161

1483

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

295

0.95

0.06

1.4

1.3

5.63

5.95

mmol/l

1.23

279

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

138

1.09

0.06

1.1

50.17

58.32

u/ml

0.21

133

(3034426) Prothrombin time (PT)

193

0.93

0.06

1.3

1.2

27.39

28.69

0.48

193

(3044007) Cell count panel - Peritoneal fluid

213

0.94

0.06

2.6

1.9

—

(3035880) pH of Pleural fluid

345

1.04

0.06

1.1

1.4

7.39

7.40

0.07

235

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

130

1.08

0.04

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

417

1.03

0.04

1.7

1.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

180

1.06

0.04

1.1

1.2

5.34

13.89

pmol/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

154

1557

0.99

0.03

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

803

0.98

0.03

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

261

1.03

0.02

1.7

2.0

23.37

31.24

1.54

261

(3048879) Bone marrow aspiration report

162

1.05

0.02

1.6

1.8

—

2.00

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

178

0.95

0.02

1.6

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

127

0.94

0.01

1.5

2.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

213

1.03

0.01

1.6

2.0

3.30

1.76

ratio

1.95

203

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

243

1.03

0.01

1.1

14.32

4.68

u/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

174

1.03

0.00

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

484

1.01

0.00

2.1

2.0

1.88

1.54

u/field

0.32

256

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

796

0.99

0.00

1.6

1.5

61.78

60.68

ug/l

0.08

656

(3016228) CD19 cells/cells in Blood

263

0.99

0.00

1.5

2.0

9.00

7.68

0.36

252

(3036048) Francisella tularensis Ab [Titer] in Serum

134

0.97

0.00

1.1

—

260.00

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

174

0.98

0.00

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

773

1.00

0.00

1.3

1.4

0.25

0.35

nmol/l

1.44

577

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

125

1.04

0.00

2.8

3.8

44.38

65.00

u/l

0.61

120

(3015076) Soybean IgE Ab [Units/volume] in Serum

265

1.02

0.00

1.1

1.0

0.15

1.59

u/ml

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

865

1.01

0.00

1.1

1.55

1.52

g/l

0.34

789

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

190

1903

1.00

0.00

1.3

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

134

1339

1.00

0.00

1.5

149.99

174.57

pmol/l

0.26

129

1305

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(44806071) Cardiolipin IgM antibody measurement

0.98

-0.00

1.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.2

—

18.74

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

304.80

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.87

-0.00

14.7

9.1

0.28

0.20

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.46

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.14

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

110

1.00

-0.00

1.0

1.5

—

5345.83

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

330

1.00

-0.00

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.91

-0.00

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

6.88

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.00

-0.00

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

4.40

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_MUSCULOSKELEOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_MUSCULOSKELEOTH	1.409 [1.26, 1.58]	< 0.001
Birth year	0.997 [0.99, 1.0]	0.409

During the follow-up period (1.1.1998 — 31.12.2019), 2181 out of 11712 females with M13_MUSCULOSKELEOTH died.

Males

Parameter	HR [95% CI]	p-value
M13_MUSCULOSKELEOTH	1.31 [1.17, 1.47]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 1812 out of 10577 males with M13_MUSCULOSKELEOTH died.

Mortality risk

Mortality risk for people of age

years, who have M13_MUSCULOSKELEOTH.

N-year risk	Females	Males
1	0.159%	0.27%
5	0.828%	1.402%
10	2.178%	3.571%
15	4.184%	6.955%
20	7.422%	11.411%

Relationships between endpoints

↥

Index endpoint: M13_MUSCULOSKELEOTH – Other disorders of the musculoskeletal system and connective tissue

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other disorders of the musculoskeletal system and connective tissue

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints